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One third of the world’s population is infected with Mycobacterium tuberculosis (Mtb). 
Although most infected people remain asymptomatic, they have a 10% lifetime risk of 
developing active tuberculosis (TB). Thus, the current challenge is to identify immune 
parameters that distinguish individuals with latent TB from those with active TB. Using human 
and experimental models of Mtb infection, we show that organized ectopic lymphoid structures 
containing CXCR5
+
 T cells are found in Mtb-infected lungs. In addition, we show that in 
experimental Mtb infection models, the presence of CXCR5
+
 T cells inside ectopic lymphoid 
structures are associated with immune control. Furthermore, in a mouse model of Mtb infection, 
we show that activated CD4
+
 CXCR5
+
 T cells accumulate in Mtb-infected lungs, and produce 
proinflammatory cytokines. Absence of CXCR5 in mice results in increased susceptibility to TB 
due to defective T cell localization within the lung parenchyma. We show that CXCR5 
expression on T cells mediates correct T cell localization within TB granulomas, efficient 
macrophage activation, promoting protection against Mtb infection and facilitating lymphoid 
follicle formation. These data show a novel role for CD4
+ 
CXCR5
+
 T cells in protective 
immunity against TB and highlight their potential use for future TB vaccine design and therapy. 
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1.0  INTRODUCTION 
1.1 MYCOBACTERIUM TUBERCULOSIS  
Twenty years ago, the World Health Organization declared TB a global health emergency. The 
disease, caused by the bacterium Mtb, most commonly affects the lungs. Transmission occurs 
from person to person through aerosol droplets generated through the cough of someone with an 
active respiratory Mtb infection. Even though a TB vaccine exists and an effective drug regimen 
is available, TB still ranks as the second leading cause of death from an infectious disease in the 
world, only behind Human Immunodeficiency Virus (HIV). The ever increasing global health 
burden of TB can be contributed by a number of factors including: 1) the emergence and growth 
of multi-drug resistant (MDR) and extensively drug resistant (XDR) strains of Mtb; 2) social 
inequality and widespread poverty; and 3) the increasing acquired immunodeficiency syndrome 
(AIDS) epidemic. Despite this dismal outlook, hope lies in the growing body of immunological 
knowledge and new scientific tools at our fingertips in providing novel breakthroughs in the 
treatment and prevention of TB. 
1.1.1 Disease Outcomes 
The clinical manifestation of TB is diverse and depends on a number of host factors and host-
microbe interactions 
2
. Following initial exposure to Mtb, several disease outcomes are possible: 
 2 
active disease, latent disease, and reactivated disease (Figure 1) 
2
. Although active TB and 
reactivated TB place the largest strain on health care systems, only a small proportion of those 
infected actually develop symptoms. Approximately 5-10% of the population will develop a 
primary infection with clinical symptoms of active disease. Symptoms typically develop within 2 
years of the initial infection and most commonly include coughing, fatigue, fever, and chest pain 
3
. The disease primarily affects the lungs, the initial site of infection, but the infection can spread 
to other organs such as the spleen, lymph nodes, liver, joints, peritoneum, kidneys, and central 
nervous system causing widespread symptoms and damage. Patients with active disease are 
typically placed on a combination drug therapy including isoniazid, rifampin, pyrazinamide, and 
ethambutal for 6 months or longer 
4
. Incomplete drug treatment for active disease contributes to 
the growing MDR and XDR TB cases worldwide and has prompted the implementation of the 
Figure 1: The progression of Mtb infection in humans. 
Following aerosol exposure to Mtb, approximately 5% of individuals develop active disease within the first two years. 
Others develop latent infection, which 90% maintain for life. However, 5-10% of individuals reactivate TB. The 
immune conditions and cellular architecture required for maintaining immune control during latent infection require 
further investigation. Figure modified from previous work 
1
. 
 3 
Directly Observed Therapy, Short Course (DOTS) regimen 
4
.  
Active TB may be the primary cause of TB hospitalizations, but latent TB is the largest 
reservoir of the tubercule bacilli. The majority of cases, approximately 90%, of individuals 
infected with Mtb are able to mount a protective cell-mediated immune response that inhibits the 
growth of the mycobacteria without complete eradication 
5
. This is referred to as a latent TB 
infection. These patients are characterized as having a positive skin reaction to tuberculin, but 
having no observable symptoms of pulmonary or extrapulmonary TB 
5
. In contrast to active  
disease, latent Mtb-infected individuals are not considered infectious. 
If latent TB were controlled throughout the life of the person, it would pose no eminent 
threat to the host or close contacts. However, 10% of latently infected individuals reactivate and 
develop post-primary active TB 
4
. Factors such as age, immune status, malnutrition, smoking and 
coexisting diseases are known to increase risk of reactivation, but detection methods to 
determine those that will and those who will not reactivate are ill defined 
4
. It is becoming clear 
that latency encompasses a wide range of conditions and by determining the molecular and 
cellular differences between active and latent TB, it may be possible to identify patients who are 
at risk for reactivation.  
1.1.2 The TB Granuloma 
The hallmark characteristic of TB is the granuloma where it is easily identified on chest x-rays in 
activated, latent, and reactivated infection. At the most rudimentary level, the granuloma is an 
organized immune cell aggregate composed of infected macrophages at the center surrounded by 
a dense leukocytic wall 
6
. The granuloma is thought to be a protective defense to concentrate the 
immune response for effective bacterial killing and to prevent mycobacterial spreading 
7
. 
 4 
However, the observation that granulomas develop in both latent and active infection suggests 
that formation is inadequate for protection. Further, in active infection, the caseous core can 
foster an environment where extracellular bacteria can exist and where increased cell death in the 
granuloma can act as a nutritional source for replicating bacteria 
8
. The granuloma can also act as 
an infectious source to seed new granulomas within the lung 
9
. Thus, a very delicate and dynamic 
balance between Mtb replication and the immune response must be maintained. By identifying 
the cellular differences and biomarkers characteristic of latent and active granulomas, we may 
further understand what specific granulomatic structure sustains long-term bacterial control. 
In humans, a spectrum of granulomas are observed in TB, but the classic granuloma is 
caseous, meaning it has a necrotic core. Mtb-infected macrophages are clustered at the center 
where they can undergo a number of changes including the fusion into multinucleated giant cells 
and/or differentiation into foam cells 
6, 10
. Macrophages constitute the majority of the cells within 
the granuloma. As immune cells infiltrate the lung, a leukocyte cuff forms containing CD4
+ 
T 
helper (Th) cells, CD8
+ 
T cells, natural killer (NK) cells, dendritic cells (DCs), neutrophils, and 
fibroblasts. B cells form distinct lymphocytic aggregates and epithelial cells are also known to 
contribute to the formation of this complex and dynamic structure. The increased number of 
immune cells and Mtb-infected macrophage cell death form the caseum within the granuloma, 
which increases in size as the infection progresses 
7
. Cytokine production is primarily localized 
in the periphery of the granuloma where it is thought that the majority of cross-talk occurs rather 
than in the core 
11-12
. The receptors required for localization of these critical immune cells within 
the granuloma is a significant area of investigation. 
 5 
1.1.3 Animal Models 
TB is a disease that only occurs naturally in humans. However, studying human TB can be 
challenging with considerable variation in age of the subject, duration of infection, bacterial 
strains, and genetic differences. Not to mention, patients with latent and active infection and 
those receiving antibiotic treatment further contribute to disease diversity. Fortunately, TB 
research has several animal models for studying infection, although many aspects should be 
considered when selecting an appropriate animal model. The primary animal models used for 
Mtb infection research include the non-human primate (NHP), the mouse, the guinea pig, and the 
rabbit, with the mouse considered the most commonly used animal model. An important issue 
with other regards to TB research is the need for a biosafety level (BSL)- 3 facility. As such, 
several other mycobacteria animal models have developed, such as the zebrafish model infected 
with M. marinum, that are suitable for BSL-2 work. 
Historically, the guinea pig was the first model used by Robert Koch, the original pioneer 
of TB research, when he infected a guinea pig with infectious brain or lung tissue from humans 
who died of TB 
13
. The lung pathology of a guinea pig is very similar to humans with large 
mononuclear cells that undergo necrosis forming caseous granulomas. However, guinea pigs are 
highly susceptible to infection and limited reagents are available for study 
14
. Further, rabbits 
develop similar lung pathology as humans with more innate resistance to TB, however, similar 
limitations as the guinea pig also exist with this model 
15-16
.  Recently, zebrafish have become an 
excellent model for real-time visualization of granuloma development using M. marinum as 
these fish embryos are transparent 
17
. Although caseous granulomas develop in the zebrafish, 
lesions contain few lymphocytes suggesting innate immunity may play a larger role in 
 6 
granuloma formation in zebrafish 
18
. Despite limitations to this model, new insights into host 
immunity are obtainable with the ease of new technology and genetics available. 
The most exploited model in TB is the mouse model 
19
. It is both economical and easily 
manipulated, with a vast amount of immunological resources available. Various routes of 
infection including intravenous (i.v.) and the low dose aerosol model have been utilized for Mtb 
infection. Intravenous delivery of Mtb is advantageous in that it produces a considerable host 
immune response with a systemic infection. However, the immune response to systemic 
infection differs substantially from an infection through a natural aerosol route where fewer 
bacteria are deposited directly in the lung. Chiefly, a considerable amount of bacteria is required 
for i.v. infection to infect the lung as bacteria circulate and reside in the spleen and liver 
20
.  
Further, bacteria are also deposited within the parenchyma of the lung rather than the alveoli as 
seen in an aerosol infection. The development of specialized equipment to deliver ~100 colony 
forming units (cfu) of Mtb bacteria, which is considered a low dose of Mtb, has made the use of 
the aerosol model more convenient. Microscopic aerosol droplets are deposited in the lower lung 
closely mimicking a natural TB infection making it the most acceptable route of infection 
21-22
. 
Some limitations exist in the mouse model of tuberculosis namely differences in 
granuloma development and the inability to naturally develop latent TB. Mtb-infected mice 
develop a chronic infection that persists throughout the life of the mouse 
23
. Further, the 
granulomatic response, which begins to develop around day 21 post infection, does not progress 
to a necrotic phase, except in certain strains of mice 
24-25
. The murine granuloma starts with the 
accumulation of macrophages followed by infiltration of lymphocytes and the organization of 
distinct CD4
+
 T cells aggregates and interspersed CD8
+
 T cells throughout the lung. Tight 
clusters of B cells can also be observed in the granuloma 
24
. Human granulomas are more 
 7 
structured in comparison to the mouse granuloma, however, great insights into granuloma 
development have resulted from murine TB research. The versatility of the mouse model with its 
capacity for genetic manipulation and vast immunological resources make it an ideal model for 
determining protective immune mechanisms against Mtb. 
Although the mouse model has contributed immensely to our understanding of TB, it 
does not reproduce classical latency. This deficiency can be overcome with the use of NHPs, 
which develop various types of pathological lesions and outcomes similar to human infection 
26
. 
Mtb granulomas contain a classical structure of multinucleated giant cells and caseation with 
liquefacation and cavity formation occurring in the NHP lung with active TB. Cost, containment 
requirements, and ethical concerns for NHP research has limited the use of this model in TB, but 
it still remains our greatest resource in studying latent TB and for examining TB/AIDS co-
infection and reactivation 
26
. 
1.2 MTB HOST DEFENSE 
1.2.1 Initiation of Infection 
The first line of defense against aerosolized Mtb is the alveolar macrophage within the lung. 
Although crucial for eliciting an immune response, the macrophage is also used by the bacterium 
to evade immune recognition and destruction ensuring survival within the host. Several pattern 
recognition receptors (PRRs) are implicated in the internalization of Mtb, namely complement 
receptors (CR) 1, 3, and 4, CD14, the mannose receptor, scavenger receptors and the pulmonary 
surfactant protein (Sp-A) 
27-31
. Once inside the host cell, the maturation of the phagosome is a 
 8 
relatively short process.  However Mtb arrests phagosome development and prevents lysosome 
fusion 
32
. The inability of the macrophage to proceed through this pathway is thought to be 
dependent upon the bacterial expression of surface manosylated lipoarabinamannam (ManLAM) 
and other Mtb lipids such as PIMs that prevents the acquisition of lysosomal hydrolases 
33-36
. The 
arrest of the phagosome provides an ideal environment for Mtb replication and evasion from the 
host that requires adaptive immunity to overcome. 
The development of adaptive immunity is dependent on the uptake of Mtb antigen by 
antigen presenting cells (APCs) mainly dendritic cells (DCs), but also macrophages and B cells. 
DCs, in addition to complement receptors and the mannose receptor, also express DC-SIGN 
(DC-specific intercellular adhesion molecule-3-grabbing nonintegrin), which interacts with Mtb 
surface carbohydrates for cellular uptake 
37-38
. In contrast to human macrophages, DCs prevent 
intracellular growth of Mtb and are able to upregulate activation markers following 
internalization through DC-SIGN and signaling through toll-like receptors (TLRs) 2, 4, and 9 
38-
41
.  Mtb-stimulated  DCs traffic to the lymph node following maturation and upregulation of the 
CC-chemokine receptor CCR7 where they present antigen to naïve T cells and produce    
proinflammatory cytokines initiating the T cell adaptive immune response. T cell priming occurs 
in the mouse model 8-10 days following challenge 
42-44
. Additionally, IL-12p40 is required to 
induce chemokine responsiveness of Mtb-exposed dendritic cells as IL-12p40 deficient DCs 
were unable to migrate from the periphery to secondary lymphoid organs (SLOs), but could be 
rescued with the addition of IL-12p40 homodimer 
45-46
. 
A major consequence of Mtb induced macrophage and DC activation is the production of 
proinflammatory cytokines and chemokines (Mtb cytokine and chemokine secretion will be 
discussed in depth in section 1.3 and 1.4, respectively) responsible for initiating immune cell 
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recruitment for granuloma formation and for shaping the adaptive immune response. In the 
mouse model, this cytokine and chemokine production can be detected in the lung starting at day 
15 post infection and coincides with cellular accumulation and control of the bacterium 
24
. 
Cytokines can induce activation of macrophages and killing of Mtb by driving production of 
reactive oxygen intermediates (ROIs) and inducible nitric oxide synthase (iNOS). It is clear, that 
Th1 skewing cytokines, namely interferon (IFN)- and tumor necrosis factor (TNF)- produced 
by other innate or adaptive immune cells in close proximity to Mtb-infected macrophages drive 
this process.  
1.2.2 CD4+ T Helper Cells  
It is well established that CD4
+
 T helper cells are critical in protection against Mtb in 
both mice and humans 
47
. Patients infected with HIV-1 are estimated to have a 30 times greater 
risk of developing tuberculosis. Mice deficient of CD4
+
 T cells succumb ~120 days post 
infection with increased neutophilic influx and reduced lymphocyte accumulation in the lung 
48
. 
Following Mtb infection, distinct activation profiles of DCs drive naïve T helper cells to become 
polarized into Th1, Th17, or T regulatory (Treg) phenotypes in the draining lymph node. These 
cells then migrate to the lung in response to Mtb-induced chemokines to elicit effector functions 
by day 15 post challenge in the mouse model 
49
. Th1 cells, which are driven by IL-12p70 
production and the expression of T-bet, are thought to be the primary cells responsible for 
bacterial control by IFNand TNFinduced macrophage activation 50. The arrival of antigen-
specific Th1 cells correlates with cessation of bacterial growth in the lungs of Mtb-infected mice 
51
. Th1 cells localized near Mtb-infected macrophages are essential for cross-talk and subsequent 
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activation and microbial killing in the lung 
52
. It remains undisputed that the CD4
+
 Th1 pathway 
is critical for Mtb protective immunity. 
Th17 differentiation is initiated by IL-6, IL-1, and TGF- production and requires IL-23 
for maintenance 
53-56
. In recent work, Th17 cells were found in the lung following infection with 
Mtb, however, the absence of IL-23/IL-17 did not result in increased susceptibility early in 
infection 
57
. IL-23KO mice had reduced inflammation within the lung, but similar bacterial 
numbers as control mice prior to day 100 post infection, suggesting  Th17 cells do not play a key 
role in early adaptive immunity 
57-58
. However, IL23KO mice had higher bacteria after 100 days 
indicating a role in chronic Mtb host defense. In contrast, Th17 cells are essential in generating 
protective memory responses in several vaccine models
59
. Thus, our expanding knowledge of 
Th17 cells in Mtb infection is rapidly evolving and will be beneficial in the design of an effective 
vaccine. 
Treg cells induced by IL-6 and TGF- cytokines and the expression of FoxP3 are critical 
in homeostatic regulation, but overproduction can lead to lack of infection control 
60
. Foxp3
+
 
Treg cells are found in the lung during Mtb infection and are specifically localized within the 
granuloma and peribronchial regions 
61
. Selective depletion of Foxp3
+
 cells in mixed bone 
marrow chimeric mice resulted in 10-fold less bacteria in the lungs of Mtb-infected mice 
61
. 
Further, adoptive transfer of antigen-specific Foxp3
+
 Treg cells prevented effector cell expansion 
and increased the bacterial burden in the lung suggesting that Tregs are primarily detrimental to 
the generation of a protective immune response in Mtb infection 
62
.   
The involvement of newly emerging cell subsets such as T follicular helper cells, Th22 
cells, and Th9 cells in Mtb infection remain to be defined. In addition, it is now understood that 
T helper cells may possess some degree of plasticity 
63
. The phenotypic flexibility of these 
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subsets in host defense against Mtb may be advantageous allowing the T helper cell to adapt to 
various immune environments as the infection progresses. It is becoming clear that 
multifunctional IFN+TNF+IL-2+ Th1 rather than single positive IFN+ Th1 cells correlate with 
better protective immune responses against Mtb 
64
. The plasticity of all CD4
+
 Th cell subsets is 
an important focus for future study in Mtb infection. 
1.2.3 CD8+ T cells 
It is generally accepted that CD4
+
 T cells are critical during Mtb infection, but evidence for 
CD8
+
 T cell involvement has been lacking. CD8-deficient mice are not more susceptible and 
have no defects in granuloma development, despite the presence of CD8
+
 T cells in peripheral 
lesions of the lung 
65-66
. Although, this early evidence shifted the primary focus to CD4
+
 T cells, 
further analysis suggests that CD8
+
 T cells may also be required for optimal defense against Mtb 
infection. During the chronic phase of infection, CD8-deficient mice were reported to have 
increased lymphocytic and neutophilic influx 
65
. In addition, antibody depletion studies suggest 
both CD8 and CD4 cells are needed during Mtb infection, although the role for CD4
+
 cells is 
more prominent in the murine model 
67
. In addition, adoptive transfer of immune CD8
+
 T cells 
reduced the bacteria burden within the lung of Mtb-infected mice 
20, 68
. In humans, Mtb specific 
CD8
+
 T cells were found to directly kill Mtb-infected macrophages through granulysin 
production 
69-70
. Additional evidence has shown that CD8
+
 T cells produce the proinflammatory 
cytokines IFN and TNFto further contribute to bacterial control 71. Thus, it is clear that CD8+ 
T cells are involved in Mtb infection and interact with CD4
+
 T cells to contribute to the outcome 
of TB 
72
. 
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1.2.4 B cells 
The function of B cells and antibodies in TB remains an enigma. Although important for 
numerous microbial pathogens in protection and immunological memory, B cells, by themselves, 
are thought to confer little protection against TB 
73
. Historically, passive immune therapy was 
used to transfer humoral immunity with variable protective results, and was replaced by the 
advent of antibiotics as a superior treatment 
74
. Variability in passive immunity is likely 
contributed to differences in the preparation of antisera and treatment durations. Further, B cell 
deficiencies in both humans and mice fail to increase susceptibility to Mtb infection, questioning 
whether B cells markedly participate in Mtb immunity 
75-77
. However, B cell aggregates are a 
dominant structure in both human, NHP, and mouse Mtb-infected lungs and become more 
organized as the infection progresses 
11, 24, 78-79
. The absence of B cells in mice disrupts 
granuloma formation and increases pulmonary inflammation indicating B cells are required for 
maintenance of pulmonary host architecture and for retaining the host immune balance in the 
Mtb-infected lung 
77
. Many questions remain to be answered on the role of these structures in 
Mtb immunity and whether B cells play a greater role towards protection. 
1.3 CYTOKINES IN MTB INFECTION 
Resistance to Mtb is dependent upon cellular signals initiated by Mtb-specific lymphocytes to 
activate macrophage killing mechanisms. Experimental models have firmly established that these 
soluble factors, or cytokines, are responsible for the cell-to-cell communication instigated in 
inflammation. Cytokines are vital for a vast number of innate and adaptive immune responses in 
 13 
TB for regulating not only macrophage activation, but inducing the differentiation of leukocytes, 
driving granuloma formation, and maintaining a balanced host microenvironment. In the mouse 
model of Mtb, induction of cytokine and effector molecules specific to the Th1 pathway, namely 
IL-12, IFN-, TNF-, and iNOS occurs between days 15-21 and coincides with T helper cell 
accumulation within the lung  
80
. The functions of these proteins in host resistance to Mtb are 
well documented in both the mouse model and Mtb-infected humans. 
1.3.1 Interleukin-12 
Mtb is a potent inducer of the multifunctional cytokine IL-12, which can be expressed as either a 
homodimer (IL-12p402) or a heterodimer composed of IL-12p40 and the IL-12p35 subunit (IL-
12p70) 
81
. In the mouse model, both IL-12p35 and IL-12p40 deficient mice are more susceptible 
to Mtb infection compared to wild type controls.  However, a deficiency in IL-12p40 is more 
detrimental to the host compared with IL-12p35 deficiency, suggesting a role for IL-12p40 
outside of IL12p70 expression 
50, 82
.  IL-12p40 is induced early in infection in response to TLR 
stimulation predominantly by macrophages and DCs and signals through the IL-12 receptor 
formed by the IL12R1 and 2 chains. Signaling through this receptor on DCs by the IL-12p40 
homodimer, activates the homing ability of Mtb-primed DCs for migration to secondary 
lymphoid organs 
45
. In the absence of IL-12p40, mice failed to generate activated CD4
+
 Th1 cells 
due to the inability of DCs to become responsive to homeostatic chemokines that drive migration 
from the lung to the draining lymph node (DLN) 
45
. Activation of DCs could be restored with 
treatment of IL-12p402, and IL-12p40 deficient mice can be partially rescued with administration 
of exogenous IL-12p402 
45, 82
.  Upon arrival of DCs to the DLN, IL-12p70 is instrumental in 
driving the differentiation of naïve T cells to a Th1 phenotype 
81
. Th1 cells migrate to the Mtb-
 14 
infected lung where they are responsible for producing IFN and TNF proinflammatory 
cytokines. IL-12 is further required to maintain pulmonary Th1 effector function during chronic 
Mtb infection 
83
. The important role for IL-12 pathway is emphasized in human patients with 
Mendelian defects in IL12R1 and IL-12p40 who demonstrate increased susceptibility to 
mycobacterial infections 
84
. Recently, human dendritic cells producing IL-12 are demonstrated to 
also drive naïve T helper cell induction of a T follicular helper cell phenotype and CXCR5 
expression suggesting newer cell subsets may evolve under Mtb Th1 cytokine conditions 
85
. 
1.3.2 Interferon-
The importance of IFNin mycobacterial protection is clearly demonstrated by the severity and 
increased susceptibility to mycobacterial infections in individuals with defects in IFN signaling 
pathways 
86
. The major defined effect of IFNis the activation of macrophages by signaling 
through the IFNreceptor comprised of two subunits, R1 and R2. Activation stimulates 
antimicrobial expression of LRG47 and nitrogen and oxygen radical intermediates that can kill 
the intracellular pathogen 
87-88
. Recently, IFN has been linked to induction of autophagy known 
to reduce Mtb intracellular bacterial burden within phagocytes 
89
. However, macrophages are not 
the only cell acted upon by IFN. New evidence suggests that IFN is a powerful 
immunomodulator of non-hematopoietic cells, as bone marrow chimeric mice deficient of IFNR 
within lung epithelial and endothelial cells were unable to control chronic Mtb infection 
90
.  
During Mtb infection, numerous cell subtypes have been identified in both mice and 
humans that are capable of producing IFN namely CD4+ Th cells, CD8+ T cells and NK cells 72, 
91
. As a result, it is often difficult to assess the major cell contributor of IFNas mice deficient in 
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one cell subset compensate production with another. However, IFN protection is a key function 
of CD4
+
 Th cells. In the Mtb-infected mouse, ~5% of pulmonary leukocytes are producing IFN 
without restimulation 
72
. Further analysis determined that ~90% of IFN producing cells were 
CD3
+
 T cells, of which ~65% were CD4
+
 T cells and ~35% were CD8
+
 T cells confirming that 
Th1 cells are significant producers of IFN during Mtb infection 72. However, adoptive transfer 
of antigen-specific IFN deficient CD4+ T cells into IFN-/- mice controlled Mtb infection 
compared with transferred wild type CD4
+
 T cells indicating other CD4-dependent Mtb 
protective mechanisms exist 
44
. In addition, a mouse lacking any component of the IFN 
signaling pathway, IFN, IFNR, and STAT1 remains one of the most susceptible genetically 
modified animals to date in Mtb infection with high bacterial burdens, large infiltration of 
polymorphonuclear neutrophils and extensive necrosis 
92-93
. Increased neutophils in mice 
deficient in IFNsignaling pathways is due to regulation of IL-17 by IFNas IL-17 is known to 
control neutrophil recruitment 
94
.  It is clear that IFN is essential to restrict bacterial replication 
and prevent fatal infection in Mtb-infected humans and mice.  
1.3.3 Tumor Necrosis Factor-
TNFis another potent proinflammatory cytokine in Mtb infection as definitely proven by 
multiple studies with genetically modified mice, soluble TNF receptors, and blocking antibodies 
95
. Likewise, patients with severe autoimmune disease are treated with immunosuppression 
therapy using TNFblockers that increase the risk of developing reactivated TB demonstrating a 
critical role for TNF in control of Mtb infection 96-97. TNF- can exist in both soluble form and 
membrane bound and is known to act through the trimeric receptors, TNFR1 and TNFR2 
95
. 
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Mice deficient in TNF have an initial delay of cellular influx into the lung, where recruited T 
cells fail to colocalize with macrophages, and necrosis ensues 
98
. TNF-/- mice begin to 
succumb to infection ~28 days post infection following low dose, aerosol Mtb infection 
98
. 
Chronic Mtb-infected mice and NHPs that were TNF neutralized had increased tissue bacterial 
burden with fluid accumulation in the alveolar space 
99-100
. The heightened bacterial burden in 
TNF gene deficient mice is attributed to the bactericidal activity of TNFin activating 
macrophages that is synergistic with IFN. In addition, TNF is important for chemokine 
production in macrophages and the subsequent recruitment and organization of immune cells 
into the granuloma 
98, 101
. In vitro assays have demonstrated that Mtb-infected murine 
macrophages neutralized with TNF have decreased levels of the chemokines CCR5, CXCL9, 
and CXCL10 
103
. Further, mice deficient in TNFexhibit disrupted granuloma formation in the 
lung, likely attributable to decreased chemokine production 
101
. Cells primarily responsible for 
TNF production in humans and experimental models include macrophages and antigen specific 
CD4
+
 T cells and CD8
+
 T cells 
71, 104-105
. It has further been described that a population of CD4
+
 
T cells are multifunctional and capable of producing both IFNand TNFand may play a role in 
Mtb host defense
. The contribution of TNFto Mtb infection is undisputable with functions 
in bacterial killing, cell survival, lymphocyte recruitment and granuloma formation. 
1.3.4 Nitric Oxide  
The production of reactive oxygen intermediates, reactive nitrogen intermediates, and LRG-47 
are  effective host defenses against infectious pathogens. NO is a signaling molecule synthesized 
when the guanidine nitrogen of L-arginine is oxidized by nitric oxide synthases (NOS), which 
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are either constitutively expressed (neuronal NOS and endothelial NOS) or induced (inducible 
NOS). Expression is driven by the production of proinflammatory cytokines TNFIFN, and 
IL-1, individually or synergistically 107. iNOS plays an essential role in  generating NO during 
Mtb infection and killing Mtb within infected macrophages in the mouse 
108-109
. Mtb-infected 
iNOS-/- mice had higher rates of dissemination and increased neutrophilic necrosis that led to 
exacerbated TB, compared with B6 control mice 
110
. In chronic infection, mice treated with 
aminoguianidine, an iNOS inhibitor, showed worsened pathology and increased bacillary load, 
while mice latently infected with Mtb, also known as the Cornell mouse model, developed 
reactivated infection 
111
.  
In contrast to the mouse model of TB, the role of iNOS in human TB remains 
controversial. Few reports have identified antimycobacterial effects of NO, however, iNOS 
expression is upregulated in human Mtb-infected granulomatic lesions 
107, 112
. Early growth 
inhibition of Mtb in human alveolar macrophages is shown to be independent of IFN- mediated 
NO activation as exogenous IFN- added to Mtb infected macrophages produced no 
antimicrobial activity 
113
. However, macrophages and epithelial cells are capable of making NO 
during Mtb infection 
107, 112-115
. One study suggests that alveolar macrophages can make NO 
when infected with Mtb and this correlated with inhibition of Mtb growth 
116
. Importantly, 
polymorphisms in iNOS in -1026G allele, rs2274894 (intron), and rs8078340 (promoter) found 
in Brazilian, African-American, and South African populations, repectively, were associated 
with increased susceptibility to TB, supporting the potential protective role for  NO in human 
infection 
117
. 
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1.4 CHEMOKINES IN MTB INFECTION 
In addition to cytokines, chemokines are critical for protective immunity against Mtb. 
Chemokines are a large family of structurally related proteins that are known to interact with a 
number of G-protein linked receptors to drive angiogenesis, development, the trafficking of 
APCs to SLOs and the recruitment of immune cells to sites of inflammation 
118-121
. Each 
chemokine is categorized into four subfamilies based on structural similarities in their first two 
of four cysteine residues: C, CC, CXC, and CX3C 
118-120
. Based on their expression in 
inflammation or in SLOs, chemokines can be further divided into inflammatory or homeostatic 
chemokines 
122
. However, it is becoming clear that homeostatic chemokines can also be induced 
in response to inflammation 
24, 123-126
. 
 The availability of several animal models of TB has greatly benefited our overall 
understanding of chemokines in Mtb infection. In the mouse model of low dose aerosol Mtb 
infection, mRNA for a number of chemokines and their corresponding receptors have been 
reported to be upregulated in the lung between days 12-21 post infection (Table 1) and this 
coincides with the recruitment of specific immune cells into the lung (Figure 2). Specifically, the 
early accumulation of a variety of different innate cells such as neutrophils, NK1.1 cells,  T 
cells and macrophages (Figure 2a), as well as later accumulation of adaptive effector cells such 
as CD4
+
 T cells, CD8
+
 T cells and B cells appear to coincide with induction of specific 
chemokine mRNAs in Mtb-infected murine lung (Figure 2b).  The coordinated expression of 
chemokines likely plays an important role in granuloma formation. Although granulomas seen in 
the mouse model of TB are not organized similar to granulomas seen in Mtb-infected humans 
and NHPs, the use of novel chemokine deficient mice in the mouse model of TB has been pivotal 
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Table 1: Chemokine Induction in Mtb-infected mice.  
Fold induction of chemokine and chemokine receptor genes in the murine lung were quantified using microarray at 
day 12 (D12), day (D15) and day 21 (D21) following M. tuberculosis infection 
80
. Table was adapted from 
127
. 
 
 
 
in documenting the individual, as well as the overlapping, and redundant roles of chemokines 
and their ligands in Mtb infection. The specific roles of inducible and homeostatic chemokines in 
Mtb infection will be further discussed. 
1.4.1 Inflammatory Chemokines in Mtb Infection 
Cellular recruitment in response to pulmonary inflammation requires the upregulation of 
cytokines, the expression of adhesion molecules on the cell surface and endothelium, and the 
production of inducible chemokines. The majority of identified chemokines are inducible, and 
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are expressed in response to inflammation. During Mtb infection, a number of inflammatory 
chemokines are produced, namely CXCR1/2 (neutrophil recruiter), CXCR3 (lymphocyte 
recruiter), and CCR2/5 (lymphocyte and myeloid recruiter) ligands (Table 1) 
80
. In in vitro 
cultures, these chemokines are produced from Mtb infected macrophages in as little as 2 hours  
with peak expression within ~24 hours post infection 
128-130
. However, in vivo detection of 
pulmonary chemokines in the mouse is delayed until days 12-21 post infection (Table 1) 
80
. The 
most highly discussed chemokines in Mtb, IFNinducible chemokines CXCL9/10/11, are 
thought to be important for the recruitment of Th1 cells to the Mtb infected lung and will be 
further discussed.  
 
 
 
 Figure 2: Timing of accumulation of immune cells in the murine lung following Mtb infection. 
Innate cells such as neutrophils,  T cells, DCs, and macrophages likely respond to early induction of chemokines 
and accumulate in the Mtb-infected lung (a). Following initiation of adaptive immune responses, cytokine-producing 
CD4
+
, CD8
+ 
T cells as well as B cells then respond to appropriate chemokines induced in the lung and accumulate to 
mount protective immune responses against Mtb infection (b). *Indicates the timing of arrival of different immune 
cells to the lung following Mtb infection determined by flow cytometry,. 
 
 21 
is an inflammatory chemokine receptor that is upregulated on naïve T cells rapidly following 
DC-induced T cell activation 
131
. T-bet, the Th1 master transcription factor directly transactivates 
the CXCR3 promoter in Th1 cells and CTL cells to mediate migration into sites of inflammation 
132
. CXCR3 is highly expressed by CD4
+
 T helper type 1 cells and CD8
+
 T cells, it is also 
detected on B cells, NK and NKT cells and results in migration towards three chemokines 
namely, CXCL9/MIG, CXCL10/IP-10, and CXCL11/ITAC 
132
. CXCL9-11 expression is 
induced during Mtb infection (Table 1) and expression is localized within TB granulomas 
133-134
. 
Further, CXCR3 expressing T cells are found in Mtb-infected NHP lungs and BAL 
134
 as well as 
Mtb-infected mouse lungs 
135
. To investigate the mechanistic role of CXCR3 in response to Mtb 
infection, Cxcr3-/- mice on the C57BL/6 background were infected with low doses of 
aerosolized Mtb, but did not show any defects in bacterial control 
136
.  However, tubercle 
granuloma formation was impaired with associated decrease in the number, size, and density of 
granulomas in the lung 
136
. Furthermore, higher expression of CXCL9 was found to differentiate 
disease severity in human TB patients 
137-138
 and a new potential protective SNP in the promoter 
of CXCL10 has been reported 
139
, suggesting that despite bacterial control in the absence of 
Cxcr3 in murine models, CXCR3 receptor and its ligands may play important roles in human 
TB. 
1.4.2 Homeostatic Chemokines in Mtb 
Constitutive expression of “homeostatic” chemokines accounts for the accumulation of naïve T 
cells, B cells and resident macrophages in SLOs, as well as for the recruitment of dendritic cells 
following antigen exposure. Four chemokines are responsible for SLO organization, specifically 
CCL19, CCL21, CXCL12, and CXCL13. Interestingly, CCL19, CXCL12 and CXCL13 mRNAs 
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are upregulated in the lung at D21 during an Mtb infection (Table 1) and play a critical role in 
protective immunity.  
Migration of T cells and DCs to the paracortical T-cell zones of secondary lymphoid 
organs is dependent upon the expression of the homeostatic chemokines CCL19 and CCL21. 
Naïve and central memory T cells, as well as DCs express CCR7 and respond to this chemokine 
gradient 
140-141
 and the expression of these chemokines are required for effective T-cell priming 
142-144
. Accordingly, following Mtb pulmonary infection, DCs upregulate CCR7 
45, 145-146
 and 
migrate to the draining lymph node 
45, 49
.Consistent with this role for CCR7 in DC migration, 
Ccr7 deficient mice exhibit impaired DC migration to the mediastinal lymph node, resulting in 
delayed dissemination of Mtb to peripheral organs 
147-148
, and delayed activation of T cells 
148
. 
Similarly, mice that have a genetic mutation leading to the loss of CCL19 and CCL21ser 
expression (plt/plt mutant mice) have defects in DC migration to the DLN 
49
 and decreased 
induction of T cells producing IFN in the lymphoid organs 24. The delayed generation of IFN-
producing activated T cells in the lymphoid organs correlated with delayed accumulation of IFN 
producing T cells in Mtb-infected lungs, and resulted in increased susceptibility to Mtb infection 
24
. These data together support a role for CCL19 and CCL21 expression in the lymphoid organs 
to mediate optimal DC migration and T cell priming during Mtb pulmonary infection.   
CXCL13, the only ligand for CXCR5, is a homeostatic chemokine expressed 
constitutively in secondary lymphoid organs 
149
 and produced by follicular dendritic cells and 
stromal cells for the specific localization of B cells and Tfh cells within the lymphoid follicle 
150-
154
. Recently, CXCL13 expression has been detected in non lymphoid tissues and associated with 
inflammation seen in conditions such as chronic obstructive pulmonary disease, rheumatoid 
arthritis and TB 
11, 155-156
. CXCL13 is upregulated during an Mtb infection (Table 1) 
80
 and 
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expression is localized specifically within lymphoid follicles containing B cells adjacent to the 
granuloma 
24, 147, 157
. In the absence of Cxcl13, integrity of the B cell follicle and formation of the 
granuloma is severally compromised 
24
. Furthermore, B cells isolated from Mtb infected murine 
lungs expressed CXCR5 and migrated to CXCL13 in vitro 
77
, suggesting that both T cells and B 
cells expressing CXCR5 may be important during TB. Accordingly, mice deficient in CXCL13 
are more susceptible to Mtb low dose aerosol infection, due to defects in correct T cell 
localization within the TB granulomas and leading to decreased macrophage activation and 
mycobacterial control 
24
. Future research will focus on delineating the specific role of CXCR5 on 
T cells and B cells in formation of lymphoid structure formation within TB granulomas and their 
specific role in mycobacterial control.   
1.5 ECTOPIC LYMPHOID FOLLICLES 
Ectopic lymphoid follicles, also known as ectopic lymphoid organs (ELOs), were first identified 
as permanent structures seen in rabbits, rats, and guinea pigs 
158
. Unlike conventional secondary 
lymphoid organs (SLOs), ELOs are not preprogrammed and develop after birth. ELOs can be 
found in nearly every organ in the body and are characterized based on location as gut associated 
lymphoid tissue (GALT), bronchus associated lymphoid tissue (BALT), nasal associated 
lymphoid tissue (NALT), mucosa associated lymphoid tissue (MALT) and conjunctiva 
associated lymphoid tissue (CALT). In humans and mice, little evidence of BALT formation can 
be found in the lung, but in response to antigenic stimulation, mice and humans can develop 
lymphoid follicles throughout the lung, known as inducible bronchus associated lymphoid tissues 
(iBALT) 
158-159
. They differ from BALT in that they do not always form near airways and can be 
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found in the parenchyma. Further, BALT contains an overlying epithelial layer and do not form 
in response to antigen. iBALT are reported to be induced during several inflammatory disease 
conditions of either autoimmune or infectious nature.  
BALT was initially described more than 30 years ago as a dominantly lymphocytic 
aggregate found mainly in the upper bronchi 
160-161
. Today, we compare these structures to SLOs 
with organized B cell follicles, separated T cell areas, macrophages, stromal cells, and follicular 
dendritic cells (FDCs) 
159
. Follicular dendritic cells have a similar function in BALT as they do 
in SLOs presenting antigen and providing co-stimulatory signals to B cells for activation and 
successive class-switching in the germinal center 
162-164
. B cells in BALT can develop into 
plasma cells as IgG cells are detected under some inflammatory conditions; however, the 
majority of cells are IgM
lo
IgD
hi  165-166
. Further, T cells are also known to interact with antigen-
loaded DCs and undergo multiple rounds of proliferation in BALT 
167
. Lymphocytes enter 
through high endothelial venules (HEV) that develop and express peripheral lymph node 
addressin (PNAd) and vascular cell adhesion molecule 1 (VCAM-1) rather than mucosal cell 
addressin cell adhesion molecule 1 (MAdCAM-1) used in Peyer’s patches 168-169. The 
inflammatory conditions required for formation of iBALT will be further discussed. 
1.5.1 Chemokine and Cytokine Induced Formation 
iBALT only appear in the lung after prolonged periods of antigen stimulation in response to 
infection or autoimmune disease disorders 
170
. It is clear iBALT is not a constitutive structure in 
the lungs of humans and mice and forms in a process called lymphoid neogenesis, which is 
thought to utilize similar mechanisms to SLO development 
168
. Homeostatic chemokines are an 
important component of lymphoid organ formation during embryogenesis and are also detected 
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within iBALT 
170
. The increased expression of CXCL13, CCL19, and CCL21 are essential for 
SLO development and immunity as mice deficient in Cxcl13 or Cxcl19 are lacking numerous 
lymph nodes and have disorganized splenic architecture 
171-172
. CXCL13 is primarily produced 
by FDCs and other reticular stromal cells in SLOs, which allow the recruitment of CXCR5+ 
cells to the B cell follicular zone 
173-174
. CXCL13 is a unique chemokine in that it is not 
redundant and will only recruit cells expressing CXCR5, namely B cells and Tfh cells 
174
. In 
addition to CCL21 and lymphotoxin (LT)-expression, ectopic expression of CXCL13 is 
known to lead directly to lymphoid neogenesis 
171
. In contrast, CCL19 and CCL21 are produced 
or expressed on HEVs, DCs, and stromal cells in the T cell zone recruiting naïve T cells and 
activated DCs expressing CCR7 
172
. These chemokines are thought to act similarly in iBALT to 
recruit and compartmentalize cells although development and structure appear to differ 
depending upon the source of inflammation. 
Although the induced expression of homeostatic chemokines can be independent of 
cytokine production in the formation of iBALT, the majority of chemokines expressed in ELOs 
is attributable to TNF family members, specifically LT-, TNF-, and LIGHT 175. In addition 
to the TNF family members, IL-17 has also been linked to iBALT development by inducing 
CXCL13 and CCL19 expression 
176
. The ELO developmental process is thought be initiated 
similar to SLOs by Lymphoid Tissue inducer (LTi) cells that drive the differentiation of 
mesenchymal cells into stromal cells through engagement of the surface receptor, LTR 177. 
These stromal cells then produce the homeostatic chemokines necessary to recruit and organize 
lymphocytes 
172
. However, recent evidence suggests initiation of ectopic lymphoid follicles does 
not parallel conventional lymph nodes. In response to LPS induced inflammation, iBALT 
develops independent of LTi cells and instead requires the transcription factors RORt and Id2 
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driven by IL-17 producing CD4+ T cells 
176
.  IL-17 promoted CXCL13 expression, independent 
of LT-, which was critical for lymphoid follicle formation 114. Despite the similarities between 
SLOs and ELOs, the early events in lymphoid follicle development and maintenance remain 
relatively unknown and require further investigation. 
1.5.2 ELOs in Autoimmune Inflammation 
Ectopic lymphoid organs often develop in autoimmune disorders 
170
. Autoreactive T and B cells 
are associated with the development of iBALT 
178
 that typically is seen in the immune targeted 
organ in such diseases as Sjogren’s syndrome 123, 179-180, rheumatoid arthritis 123, 181, multiple 
sclerosis 
182-183
, and diabetes 
184-185
. Immune targeted organs include the exocrine glands 
186-188
, 
joints and lungs 
189-190
, central nervous system 
182-183
, and the pancreas, respectively 
191
. Typical 
ELO formation contained FDCs, CD4+ and CD8+ T cells, CD20+ B cells, CD38+ plasma cells, 
and CD68+ macrophages with reticular networks 
186-188
. Further, lymphoid aggregates were 
found to contain proliferating Ki-67-expressing cells and HEVs that express PNAd similar to 
SLOs 
123, 183, 188-189, 191
. In RA, CXCL13 has been shown to be produced by FDCs and 
hematopoietic cells such as monocyte-derived macrophages (CD68+) that recruit CXCR5+ T 
and B cells 
192
. Further, induction of homeostatic chemokines is attributed to the cytokines LT-
and LT-and also to LIGHT in diabetes184, 191 . 
It is interesting to note that disease severity was associated with ectopic lymphoid follicle 
formation as patients containing highly developed germinal centers had more severe 
complications 
186. In Sjogren’s syndrome, patients containing ectopic lymphoid follicles in 
exocrine glands showed lower saliva production, indicating ELOs contribute to impairment of 
salivary gland function 
188, 195-196
. Rheumatoid arthritis patients with ELOs were found to have 
 27 
higher plasma cells in the synovium, suggesting lymphoid follicles may contribute to 
autoreactive B cell generation 
197
. Further, in multiple sclerosis patients, ELOs were associated 
with severe pathology in the cerebral cortex and aggressive clinical progression 
182
. Formation of 
these lymphoid aggregates was attributed to the expression of the homeostatic chemokines 
CXCL13, CCL21, and CCL19 and studies in gene deficient mice indicate that absence of these 
homeostatic chemokines disrupt ELO development 
184, 191, 193-194, 198-200
. However, disruption of 
ELOs did not always ameliorate disease 
200
. 
These studies demonstrate that ELO formation in autoimmune disease correlates with 
homeostatic chemokine expression, autoantibody production, and clinical symptoms.  Despite 
the presence of ELOs in autoimmunity, it remains uncertain the role these structures play in 
disease. It appears ectopic lymphoid aggregates promote autoimmunity in some diseases, but 
may be a result of the autoimmunity itself in others. Studies with transgenic mice expressing 
CXCL13, CCL19, and CCL21 generate ectopic lymphoid follicles, but do not develop 
autoimmunity indicating that additional mechanisms are required for a destructive immune 
response 
171, 201-203
. It is evident that a greater understanding of the cellular and molecular 
mechanisms in autoimmunity is required to determine the function of ELOs. 
1.5.3 ELOs in Infectious Disease 
Numerous infections are known to trigger the development of ectopic lymphoid tissues including 
Helicobacter pylori in the stomach 
204-207
, Borrelia burgdorferi in the skin 
208-210
, and M. 
tuberculosis, Klebsiella pneumonia, Pseudomonas aeruginosa, Haemophilus influenzae in the 
lung 
211
 among other infections 
212-215
. BALT formation can also be seen in other non-infectious 
lung diseases such as chronic obstructive pulmonary disease (COPD) 
156, 216
, pulmonary fibrosis 
 28 
217
, and hypersensitivity pneumonitis 
211, 218
. Despite the prevalence of lymphoid follicles in 
infectious disease, little remains known about the function of ELOs. The current understanding 
of ELO formation and function in infectious disease will be further discussed. 
H. pylori is a prevalent infection in humans that colonizes the gastric epithelium causing 
severe inflammation of the stomach lining that can be acute or chronic, but the majority of cases 
persist for years or life. Chemokines promoting neutrophil recruitment are highly elevated as the 
disease that is characterized by dense infiltration of neutrophils. However, several homeostatic 
chemokines, such as CCL21 and CXCL13, are also upregulated in the mucosa and lead to 
accumulation of lymphoid cells 
204-207, 219
. In cases of gastritis in both humans and mice, it is 
common for ectopic lymphoid follicles expressing homeostatic chemokines, CD3+ T cells, and B 
cells, and prominent germinal center structures containing HEV expressing PNAd and 
MAdCAM to form 
220
. Specifically, in humans 85% of H. pylori positive patients contained 
lymphoid follicles, which were strongly associated with a higher grade of severity 
207
. 
Futhermore, elevated levels of CXCL13 in gastric biopsies correlated with a higher degree of 
gastric inflammation and higher bacterial burden suggesting ELOs may contribute to pathology 
221
. Using a mouse model of chronic H. pylori, Cxcr5 deficient mice, which did not form 
organized ectopic lymphoid follicles, exhibited decreased Th17 immune responses and decreased 
IgA and IgG responses by B cells, but unaltered Th1 cellular responses 
126
. In addition, bacterial 
colonization was similar between wild type mice and Cxcr5 deficient mice suggesting ectopic 
lymphoid formation does not contribute to protective immunity against H. pylori 
126
. 
ELOs appear to contribute to immunity in response to influenza in mice. Using Influenza 
A/PR8/34 infection, mice deficient in SLOs were found to develop ELOs locally in the lung 
168
. 
Follicles consistently contained FDCs, organized GC B cells and CD8
+ 
T cells, CD4
+
 T cells, and 
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dendritic cells in interfollicular areas 
168
. As expected, CXCL13, CCL19 and CCL21 expression 
co-localized with ectopic cells, however, induction was independent of LT- and TNF- 124, 168. 
Interestingly, the loss of CXCL13 did not impact ELO formation in influenza infected mice, but 
was instead dependent upon CCL19 and CCL21 expression 
124
. Importantly, SLO deficient mice 
infected with influenza had delayed viral clearance, but enhanced survival 
168
. In addition, SLO 
deficient mice were capable of surviving higher doses of the virus suggesting ELOs are 
protective in influenza and perhaps less pathogenic than immune responses originating in the 
lymph node 
168
. Consistent with these data, Wiley et al. induced ELO formation 
asymptomatically in mice using nanoparticles and found pre-existing ELOs enhanced resolution 
of influenza suggesting ELOs could be a future preventative target 
222
. 
Lymphoid aggregates have been detected in the lungs of Mtb infected humans 
11, 79
, 
NHPs 
78
, and mice 
24, 147
. Further, organized lymphoid aggregates in humans were associated 
with latent TB 
223
. Typical follicles contained CD4
+
 T cells, CD8
+ 
T cells, and B cells suggesting 
these may be ELOs 
11
. However, detection of CXCR5
+
 T cells and GC B cells has not been 
assessed. The homeostatic chemokines CXCL13 and CCL19, but not CCL21, were found to be 
upregulated in the lungs of Mtb-infected mice 
24
. Further, cxcl13-/- mice and plt/plt mice were 
unable to control Mtb infection with higher pulmonary bacterial burden compared to wild type 
mice 
24
. Higher susceptibility in plt/plt mice and Ccr7-/- mice was contributed to defects in T cell 
priming as DCs were unable to migrate to draining lymph nodes to present antigen 
24, 148
. 
However, Cxcl13 deficient mice were unable to organize B cell aggregates and had decreased 
activated macrophages 
24
. These data suggest that lymphoid aggregates found in pulmonary TB 
are likely ELOs that may contribute to protective immunity. 
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The study of ELO function in infectious disease is a newly emerging field. Both CXCL13 
and CCL19/CCL21 appear to contribute to initiation of ELO formation and this can be 
dependent or independent of LT-and TNF-. The contribution of ELOs to protection or 
pathology differ between disease making further investigation critical in elucidating the 
mechanism of action. 
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2.0  ECTOPIC LYMPHOID FOLLICLES IN M. TUBERCULOSIS INFECTION 
2.1 ABSTRACT 
One third of the world’s population is infected with M. tuberculosis. Although most infected 
people remain asymptomatic, they have a 10% lifetime risk of developing active TB. Thus, the 
current challenge is to identify immune parameters that distinguish individuals with latent TB 
from those with active TB. A hallmark of pulmonary TB in both humans and experimentally 
infected animals is the formation of the granuloma that contains Mtb-infected macrophages. The 
structural differences between active TB and latent TB granulomas can differentiate important 
immune components required for protective immune control. Using human and experimental 
models, we demonstrated that organized ectopic lymphoid structures containing CXCR5+ T 
cells, follicular dendritic cells, and germinal center B cells form in the Mtb-infected lung. 
Importantly, in the non-human primate model we show that ectopic lymphoid structures are 
correlated with immune control. Further, the Mtb mouse model forms follicles similar to Mtb-
infected humans suggesting the mouse model is a valuable tool for addressing the mechanism of 
ectopic lymphoid organ development and protection. Therefore, our data demonstrate a critical 
function for ectopic lymphoid follicles in control of Mtb infection. 
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2.2 INTRODUCTION 
M. tuberculosis, is an intracellular pathogen that causes the disease tuberculosis, and infects 
about 2 billion people worldwide. Proper control of Mtb requires the colocalization of adaptive 
immune cells with Mtb-infected macrophages in the lung forming a granuloma, which acts as a 
physical barrier and promotes macrophage activation for bacterial killing 
224
. Despite the 
presence of the granuloma in active TB, these individuals are unable to control bacterial growth 
suggesting differences exist between latent and active TB granulomas. The presence of B cell 
aggregates has long been documented in human, NHP, and mouse granulomas 
11, 24, 78, 223
. In 
humans, B cell clusters are found in the peripheral rim of the granuloma and contain activated 
CD4
+
 T cells, CD8
+
 T cells, CD20
+
 B cells and antigen primed CD68
+
 monocytes/macrophages 
11
. Distinct vascularization and elevated proliferation activity in lymphoid aggregates was also 
associated with latent TB in humans 
223
. Mtb infection in cynomologus macaques identified B 
cell aggregates within the granuloma during primary infection with CD3
+
 T cells, but no CD138
+
 
plasma cells were detected 
78
. Further, B cells expressed higher levels of HLA-DR in the 
draining lymph node of macaques compared with peripheral lymph nodes suggesting B cells in 
the lung are activated although this was not specifically shown in lymphoid aggregates 
78
. 
Chronic Mtb infection in the mouse model triggers formation of pulmonary lymphoid aggregates 
within the granuloma associated with the expression of CXCL13, which is typically expressed in 
SLOs 
24, 147
. Mice deficient of Cxcl13 are more susceptible to Mtb infection with higher bacterial 
burden in the lung and are unable to form B cell lymphoid aggregates 
24
. These data suggest that 
B cell follicles within the lung likely form ectopic lymphoid organs that are required for immune 
control. In the current study, we show that B cell aggregates express the markers of bona fide 
ectopic lymphoid follicles containing follicular dendritic cells, CXCR5
+
 T cells, and germinal 
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center B cells that co-localize with the homeostatic chemokine CXCL13 in the granuloma of 
human, NHP, and mouse Mtb-infected lungs. Importantly, in NHPs that develop latent infection, 
we identified the significant association of ELOs with immune control. 
2.3 MATERIALS AND METHODS 
2.3.1 Human Tissue Samples and Patient Diagnosis 
Archival paraffin samples of human lung biopsies with diagnosis of TB were collected on a 
protocol approved by the Ethics Committee of the Instituto Nacional de Enfermedades 
Respiratorias and the Ethics Committee of the American British Cowdray Medical Center, 
Mexico City (Table 2).  All subjects were of similar socioeconomic status and unrelated to the 
third generation as determined by a questionnaire. TB cases had symptoms (weight loss >10 kg, 
cough, fever, night sweats for >1 mo, or cervical or axillary lymphadenopathy) and chest 
radiographic findings consistent with recent pulmonary TB, a positive sputum acid-fast smear 
and culture confirmed for Mtb. Once the diagnostic protocol was completed, patients were 
discharged and proper treatment was indicated.  
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Table 2: Active TB patient description. 
A-TB patients lung samples were analyzed for markers of ectopic lymphoid tissues including B cell lymphoid 
follicles, CXCR5
+
 T cells and FDC networks. 
 
 
2.3.2 Mtb Infection in NHPs 
Groups of non human primates (NHP) (Indian rhesus macaques) were used in this study at the 
Tulane National Primate Research Center as previously described following the 
recommendations of the Institutional Animal Care and Use Committee 
225
. For L-TB, NHPs 
were infected with low dose of Mtb CDC1551 (200-500cfu) by the aerosol route 
225
. Mtb 
exposure was confirmed by positive tuberculin skin test and PRIMAGAM, a quantiferon-type 
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IFN release assay specifically designed to confirm Mtb infection in NHPs. The NHPs did not 
exhibit any clinical signs of TB, as evident from normal body temperatures and weights, chest x-
rays and serum levels of acute phase proteins 
225
. For A-TB, NHPs were infected with high dose 
of Mtb CDC1551 via aerosol infection (~5000 cfu) 
226
.  Mtb exposure was confirmed by positive 
tuberculin skin test and PRIMAGAM and the NHPs exhibited clinical signs of TB, as evident 
from body temperatures, weights and chest x-rays 
226
.    
2.3.3 Mtb Infection in Mice 
C57BL/6 (B6) were purchased from The Jackson Laboratory, Bar Harbor, ME. Experimental 
mice were age-and sex-matched and used between the ages of 6-8 wks in accordance with 
University of Pittsburgh International Animal Care and Use Committee guidelines. Mtb strain 
H37Rv was cultured in Proskauer Beck medium containing 0.05% Tween 80 to mid-log phase 
and frozen in 1 ml aliquots at -70
o
C. Animals were aerosol infected with ~100 CFU (low dose) 
of bacteria using a Glas-Col airborne infection system 
227
.   
2.3.4 Morphometric Analysis and Immunofluoresence 
Lungs from mice and NHPs were inflated with 10% neutral buffered formalin and embedded in 
paraffin. Lung sections were stained with H&E stain (Colorado Histo-Prep) and processed 
routinely for light microscopy.  Formalin-fixed samples from TB patients were also used. For 
immunofluorescence, paraffin was removed from the formalin-fixed lung sections, washed with 
xylene, alcohol, and PBS.  Antigens were unmasked using a DakoCytomation Target Retrieval 
Solution and were blocked with 5% (v/v) normal donkey serum and Fc block (5 g/ml, 2.4G27).  
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Endogenous biotin was neutralized with avidin followed by biotin (Sigma-Aldrich).  Murine 
sections were probed with goat anti-mouse CD3 (M-20; Santa Cruz Biotechnology), rat anti-
mouse B220 (RA3-6B2; BD Pharmingen), inducible NO Synthase (goat anti-mouse, M-19; 
Santa Cruz Biotechnology), CXCR5 (Biotin, rat anti-mouse CXCR5; BD Biosciences), and IgG 
(FITC-donkey anti-mouse IgG; Jackson Immunoresearch). Primary Abs were detected with 
secondary Ab conjugated to Alexa fluor 568 for CD3 (Alexa fluor 568, donkey anti-goat, 
Invitrogen). Donkey anti-rat Ab conjugated to Alexa Fluor 488 was used to visualize B220 
(Molecular Probes). Some slides were incubated with PNA-FITC (SIGMA) and goat-anti PCNA 
(C-20, Santa Cruz Biotechnology). Rabbit anti-FITC, conjugated to alexa fluor 488 was used to 
amplify PNA signal (Molecular probes). To detect FDCs, slides were incubated with 
biotinylated, rat anti-mouse CD21-CD35 (CR2/CR1- Biolegend) and anti-follicular dendritic cell 
(FDCM-1, BD Pharmingen), followed by detection with SA-Alexa fluor 488 and donkey anti-rat 
conjugated to alexa fluor 488 (Molecular probes). CXCL13 production in infected lungs was 
detected with goat anti-mouse CXCL13 (R&D systems), followed by detection with donkey anti-
goat-alexa fluor 568. Human and NHP tissues were probed with rabbit anti-human ICOS 
(ABCAM), FITC, mouse anti-human CXCR5 (clone 51505, R&D Systems), and goat anti-
human CXCL13 (R&D Systems). Anti-CD3 was further used to detect CD3 lymphocytes 
(clone M-20; Santa Cruz Biotechnology). For B cells, CD20 (Mouse anti-human CD20 (L26); 
ABCAM) and IgD (Ab-1; Lab Vision Corporation) were used with PCNA (Goat anti-PCNA (C-
20); Santa Cruz Biotechnology) to detect germinal center B cells.  Follicular dendritic cells in 
human germinal centers were further detected with anti-human CD21 (Clone 2G9; Lab Vision 
Corporation). Slow fade gold antifade with DAPI (Molecular Probes) was used to counterstain 
tissues and to detect nuclei.  Images were obtained with a Zeiss Axioplan 2 microscope and were 
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recorded with a Zeiss AxioCam digital camera.  Caudal lobes from four mice per group 
underwent morphometric analysis in a blinded manner using the Zeiss Axioplan microscope, 
which determines the area defined by the squared pixel value for each granuloma, B cell follicle 
and perivascular cuff as previously described 
24
. 
2.3.5 CXCL13 In Situ Hybridization 
Mouse CXCL13 cDNA was RT-PCR amplified with primers BFJ.mCXCL13_F1 (5’- 
GAACTCCACCTCCAGGCAGA-3’) and BFJ.mCXCL13_R1 (5’- 
CTTTTGAGATGATAGTGGCT-3’). Human and macaque CXCL13 cDNA was RT-PCR 
amplified with primers (5’-AGACAGAATGAAGTTCATCT-3’ and 5’- 
GTGGAAATATCAGCATCAGGG-3’).  PCR products were ligated to the pGEM-T vector 
(Promega) and DNA sequenced. The pGEMT-CXCL13 plasmid was linearized by restriction 
digest.  Gene-specific riboprobes were synthesized by in vitro transcription using a Maxiscript 
SP6/T7 kit (Ambion) and unincorporated nucleotides were removed using RNA Mini Quick Spin 
Columns (Roche).  Paraffin embedded tissue specimens were pretreated as described 
58
, 
following deparaffinization in xylenes and rinsing in ethanol. In situ hybridization (ISH) with 
35
S-labeled riboprobes was performed at 50
o
C overnight as described 
228
, with 0.1M 
dithiothreitol included in the hybridization mix. Tissue sections were coated with NTB-2 
emulsion (Kodak) and exposed at 10
o
C for 10 days. The sections were counterstained with 
hematoxylin (Vector) and mounted with Permount (Fisher). Images were visualized using an 
Olympus BX41 microscope and captured using a SPOT RT3 digital camera (Diagnostics 
Instruments, Inc). 
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2.3.6 Statistics 
Differences between the means of experimental groups were analyzed using the two tailed 
Student’s t-test.  Differences were considered significant when p≤0.05.   
2.4 RESULTS 
2.4.1 CXCR5+ T cells accumulate within ectopic lymphoid structures of human TB 
granulomas 
Normal human lungs do not exhibit appreciable accumulation of lymphocytes or inflammatory 
aggregates 
155
. However, individuals with L-TB exhibit organized pulmonary lymphoid 
aggregates, while cellular aggregates were absent or less organized in lungs of individuals 
undergoing A-TB 
223
. We found that lung sections from 25% of A-TB patients (Table 2) showed 
accumulation of lymphocytes with features of classic ectopic lymphoid structures (Figure 3), 
containing proliferating PCNA
+
 GC B cells (Figure 3b), CXCR5
+
 Tfh-like cells  (Figure 3c) and 
CD3
+
 T cells expressed ICOS (Figure 3d). CXCL13 protein (Figure 6e) and mRNA (Figure 3f, 
g) were also detected within lymphoid aggregates. CD21
+
 follicular dendritic  
cells (FDCs) were also found within ELOs (Figure 3h). Localization of CD3
+
 T cells expressing 
CXCR5 (Figure 3c) and numerous proliferating cell nuclear antigen (PCNA) expressing CD20
+
 
B cells inside compact B cell follicles (Figure 3b) colocalized with macrophages expressing 
CD68 (Figure 3i, j), suggesting these are bona fide ectopic lymphoid structures. 
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2.4.2 Ectopic lymphoid structures are associated with immune control during TB in the 
NHP model of Mtb infection 
Since ectopic lymphoid structures were only seen in a minority of human A-TB granulomas 
analyzed, we hypothesized that generation of lymphoid structures may correlate with immune  
control, rather than active disease. Therefore, we characterized the presence of ectopic lymphoid 
structures in NHPs that were experimentally infected with aerosolized Mtb, in which similar to 
human infection, immune control results in L-TB and the absence of immune control results in 
 
 
 
Figure 3: CXCR5
+ 
T cells accumulate within ectopic lymphoid structures of human TB granulomas. 
Serial sections of FFPE lung biopsies from A-TB patients underwent H&E staining (a). Sections were analysed by 
immunofluorescence using antibodies specific to PCNA, IgD, and CD20 (b); CD3, CXCR5 (c); CD3, ICOS (d); 
CXCL13 (e); CD3, CD21, IgD (h); CD3, T-bet, CD68 (i); and CD3, IgD, and CD68 (j). All sections were 
counterstained with DAPI (blue). Germinal centers are outlined in yellow dashed lines and yellow arrows point to 
colocalization. CXCL13 mRNA was detected by ISH with a CXCL13 cRNA probe (f,g). Arrows point to strong 
areas of CXCL13 hybridization. Original magnification, x200; x600  (ISH).  
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A-TB 
225
. In support of our hypothesis, 100% of lung sections from NHPs with L-TB had well-
organized ectopic lymphoid structures (Figure 4a-top panel, Table 3) with distinct B cell follicles 
containing proliferating CD20
+
 B cells, CXCR5
+ 
T cells and CD21
+
 FDC networks (Figure 4b-
top panel). In contrast, in NHPs with A-TB, only 46% of lung samples contained ectopic 
lymphoid structures (Figure 4a-lower panel, Table 3) which were smaller, less organized and 
diffuse. Furthermore, only 33% of samples from NHPs with A-TB contained proliferating 
CD20
+
 B cells, CD21
+
 FDC networks and CXCR5
+
 T cells (Figure 4b-lower panel, Table 3).  
 
 
Figure 4: NHPs infected with Mtb contain ectopic lymphoid follicles. 
NHPs aerosol infected with Mtb CDC1551 exhibited either L-TB or A-TB as described in Materials and Methods. 
Thirteen weeks after infection or at necropsy, lung FFPE serial sections were stained with H&E (a) or with 
antibodies specific for PCNA, CD20 (a,b); CD3, IgD CXCR5 (b); and CD3, CD21 (b). All sections were 
counterstained with DAPI (blue). GC, containing large, proliferating B blasts (PCNA+CD20+) is outlines in dashed 
yellow lines. The images shown are from a typical representative section. Original magnification, x200, unless 
otherwise indicated. The data represent the mean (±SD) of values from 6-15 NHPs.  
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Table 3: Ectopic lymphoid structures are associated with latent rather than active disease during TB in NHP 
Mtb infection model. 
 
Description of frequency of NHPs with L-TB and A-TB that exhibited ectopic lymphoid structures and contained B 
cell follicles, proliferating B cells, CXCR5
+
 T cells and FDC networks. 
 
 
 
 
 
 
 
 
 
 
Figure 5: Ectopic lymphoid structures are associated with immune control during TB in NHP model of Mtb 
infection. 
 
NHPs were aerosol infected and sacrificed as mentioned in Figure 4. Lung FFPE serial sections were stained with 
H&E or with antibodies specific for PCNA or CD20. The number of granulomas (a), total area occupied by 
granulomas (b), percentage of granuloma area occupied per biopsy (c), and average size (d) and percentage of area 
occupied by B cell lymphoid follicles (e) were determined with the Zeiss Axioplan microscope. The data represents 
the mean (±SD) of values from 6-15 NHPs. **p=0.005, ***p=0.0005  
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Uncontrolled disease was also evident in NHPs with A-TB as large number of necrotic 
granulomas occupied much of the total lung area (Figure 5a,b,c); despite this, lungs from NHPs 
with L-TB had significantly larger B cell follicles, which occupied a significantly larger area of 
the lung biopsy (Figure 5d,e), contrasting with smaller B cell follicles detected in NHPs with A-
TB (Figure 5d,e). These data demonstrate that in NHPs, generation of well organized lymphoid 
structures containing CXCR5
+
 T cells and B cell follicles is associated with immune control in 
L-TB, while loss of immune control during A-TB is associated with absent or loosely organized 
lymphoid aggregates. 
2.4.3 CXCR5+ T cells localize within ectopic lymphoid follicles in murine TB granulomas 
Since CXCR5
+
 T cells were associated with immune control, we next addressed the role of CD4
+ 
CXCR5
+
 T cells in a well-established mouse model of TB, in which effective host immunity 
results in chronic infection. Although murine TB granulomas do not demonstrate all the 
characteristics of human TB granulomas 
8
, murine granulomas also form organized lymphoid 
structures (Figure 6a) containing CXCR5 expressing T cells (CD3
+
 CXCR5
+
) (Figure 6b) and 
B220
+
 B cells (Figure 6c) that bound peanut agglutinin (Figure 6d) and contained complex FDC 
networks (Figure 6e,f). In addition, CXCL13 protein (Figure 6e,f) and CXCL13 mRNA 
expression was detected inside lymphoid structures (Figure 7a) and expression increased over the 
course of infection (Figure 7b). 
 
 43 
 
Figure 6: CXCR5
+
 T cells localize within ectopic lymphoid follicles in murine TB granulomas 
B6 mice were aerosol infected with ~100 cfu Mtb H37Rv and on day 50 post infection, FFPE serial sections were 
stained with H&E (a) or analyzed by immunofluorescence for CD3, CXCR5, B220 (b); CD3, PNA, B220 (c); 
PCNA, PNA, B220 (d); CD21-CD35-FDCM1; CD11c, CXCL13 (f). All sections were counterstained with DAPI 
(blue). Yellow arrows point to CD3+ CXCR5+ T cells (a), PCNA+B220+ B cells (d) or CXCL13+CD11c+ cells (f). 
Original Magnification, 200X. One of two or more experiments shown. 
Germinal center B cells (GC B cells) were identified as large, proliferating PCNA
+
B220
+
 blasts  
2.5 DISCUSSION 
Ninety percent of all M. tuberculosis infected individuals develop an immune response sufficient 
to control and contain the infection within pulmonary granulomas 
229-230
. Containment is highly 
effective as most individuals go their lifetime without ever developing A-TB. There is a general 
consensus that the architecture of the granuloma contains Mtb-infected macrophages and 
multinucleated giant cells at the core with CD4
+
 T cells, CD8
+
 T cells, neutrophils, NK cells, and  
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Figure 7: CXCL13 mRNA is localized in ectopic lymphoid follicles of Mtb-infected mice. 
B6 mice were aerosol infected with ~100 cfu Mtb H37Rv and on day 50 post infection, FFPE 
serial sections  were analyzed by ISH to determine localization of CXCL13 mRNA expression 
using a murine CXCL13 cRNA probe (a) during different points of infection (b). Black arrows 
point to localization of CXCL13 mRNA within granulomas. Original Magnification, 100X (a), 
and 600X (b). One of two or more experiments shown. 
 
dendritic cells creating a perimeter around the infection 
7, 229
. However, the functional and 
morphological characteristics that coordinate protective cross-talk in L-TB granulomas remain ill 
defined. Recently, areas of strong vascularization, B cell aggregation, and high proliferation 
markers were identified in patients with nonprogressive tuberculomas 
223
.  Furthermore, B cell 
aggregates containing CD3
+
 T cells have been identified in humans, NHPs, and mice 
11, 24, 78, 223
. 
Using immunofluorescence, we further characterized these distinct lymphoid aggregates as 
organized ectopic lymphoid organs containing FDC networks, proliferating GC B cells, CXCR5
+ 
 T cells, and macrophages. Importantly, in NHPs that develop L-TB, we correlated the  
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organization of large organized ELOs containing CXCR5
+
 T cells with immune control, while 
A-TB ELOs were associated with disorganized and smaller lymphoid aggregates. These findings 
establish a critical association of ectopic lymphoid structures in the protective immune response 
against Mtb. 
Cxcl13 mRNA and protein were specifically expressed within ectopic lymphoid follicles 
and could not be detected in any other areas of the parenchyma or bronchovascular regions 
suggesting a critical role in Mtb induced ectopic lymphoid follicle formation. Expression of  
CXCL13 and CCL19/CCL21 is linked to ELO formation in other infectious disease such as H. 
pylori 
204-207, 219
 and influenza 
124, 168
, however, CXCL13 expression was pathological in H. pylori 
and was not required for ELO formation in influenza. CXCL13, and CCL19, but not CCL21 
have been shown to be upregulated in the lungs of Mtb-infected mice 
24
. Previous studies using 
Cxcl13 deficient mice and plt/plt mice in Mtb infection have noted disruption of B cell 
aggregates and increased bacterial burden in the lung 
24
. Plt/plt mice have a delayed 
accumulation of IFN producing T cells that is not observed in the absence of Cxcl13 24. 
Decreased recruitment of IFNproducing CD4+ T cells in the lung was attributed to a decrease in 
DC migration to the draining lymph node (dLN) resulting in a delay of T cell priming and 
proliferation 
24
. However, ccr7 deficient mice were capable of ectopic proliferation of Ag85B-
specific CD4
+
 T cells in the lung and plt/plt mice still contained B cell follicles although smaller 
than wild type mice 
24, 148
. These data suggest that CCL19/CCL21 are required for activated DC 
migration to the dLN, but decreased B cell follicle formation may be contributing to decreased 
lymphocyte accumulation rather than homeostatic chemokine expression. In contrast, Cxcl13 
deficient mice display complete disruption of B cell follicles within the lung and increased 
bacterial burden without defects in T cell priming 
24
. Further, Cxcl13 knockout mice contained 
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similar numbers of CD4
+
 T cells to wild type mice in the lung suggesting the organization of 
immune cells in ectopic lymphoid follicles assists in macrophage activation and bacterial killing 
24
. 
It has been previously noted that some granulomas are highly vascularized 
223
. 
Vascularization is required for proper oxygen and nutrient supply to support cells and this is 
more often seen in the area occupied by ectopic lymphoid organs and in the periphery of the 
granuloma 
223, 231-232
. Vascularized areas contained highly organized structures of macrophages 
and other antigen presenting cells surrounding by lymphocytes whereas active cavitary TB had 
disorganized lymphoid structures in these regions 
223
. These observations suggest that the 
formation of ectopic lymphoid follicles in the vascularized region of the peripheral granuloma 
provides an ideal environment for cross-talk between the pathogen and host cellular immune 
response. The organization of these ELOs appear to be initiated by CXCL13 expression, but the 
cells and mechanism required for the protective properties of ectopic follicles requires further 
study. 
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3.0  MECHANISMS UNDERLYING ECTOPIC LYMPHOID FOLLICLE 
FORMATION AND PROTECTION IN M. TUBERCULOSIS INFECTION 
3.1 ABSTRACT 
M. tuberculosis induced granulomas are central in providing conditions that promote immune 
cell interactions and bacterial containment. However, granulomas are present in both latent and 
active TB indicating structural and mechanistic immune differences must exist in granulomas 
that govern disease outcome. Recently, we have discovered that Mtb-infected lungs contain 
ectopic lymphoid follicles that correlate with protective immune control. To mechanistically 
address the cellular components necessary for protection and formation of ectopic lymphoid 
follicles, the TB mouse model was utilized. We discovered CXCR5
+
 B cells and CD4
+
 T cells, 
that produced Th1 proinflammatory cytokines, accumulated in the Mtb-infected lung. Further, 
mice deficient in Cxcr5 were more susceptible to Mtb infection and do not form lymphoid 
follicles due to improper localization of CD4
+
 T cells in the parenchyma, resulting in decreased 
macrophage activation. Defects in Cxcr5 deficient mice could be rescued by the transfer of B6 
CD4
+
 T cells, but not Cxcr5-/- CD4
+
 T cells. Finally, IL-6 and IL-21, cytokines important for T 
follicular helper cell CXCR5 expression, were required for optimal lymphoid follicle formation, 
but not for Mtb protective immunity. Our data demonstrate that CD4
+
CXCR5
+
 T cells play a 
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protective role in the immune response against TB and highlight their potential use for future TB 
vaccine design and therapy. 
3.2 INTRODUCTION 
Tuberculosis causes 2 million deaths a year despite the majority of infected individuals never 
developing symptoms 
233
. The hallmark characterisitic of TB is the formation of the pulmonary 
granuloma, which requires coordination of multiple chemokines to recruit and organize immune 
cells 
127
. Specific chemokine receptors have been implicated as important contributors to 
leukocyte accumulation, namely CXCR3 in the recruitment of T cells, CCR2 for macrophages 
and T cells, and CCR5 on myeloid cells  (discussed in detail in Section 1.4). Further, the 
homeostatic chemokine CXCL13 is induced in the Mtb-infected lung and is critical for 
protective immunity 
24
. CXCL13 is unique in that it is one of few chemokines that is non-
redundant; there is only one receptor and one ligand. Its corresponding receptor, CXCR5, is 
expressed on Tfh cells and B cells and is responsible for the recruitment and organization of cells 
in the B cell follicle of SLOs  
151, 153, 234
.  
Tfh cells are typically found within SLOs strategically positioned at the T-B cell border 
where they provide support for B cell expansion and differentiation by producing various 
cytokines, namely IL-21 
235-236
. High surface expression of ICOS and PD-1 on Tfh cells act as a 
co-stimulatory molecule inducing production of B helper cytokines and promoting long lived 
plasma cells, respectively 
237-238
. Differentiation of Tfh cells is induced by IL-6 and IL-21 acting 
through STAT-3 to upregulate the transcription factor BCL-6 
239-243
. In addition, IL-12 produced 
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by human DCs was capable of driving differentiation of IL-21 producing Tfh cells suggesting 
Tfh cells may thrive in a Th1 environment 
85, 244
.  
B cells also express CXCR5 for positioning within the follicles of SLOs and ELOs 
151, 234
. 
The role of B cells (as described in section 1.2.4) is very much an enigma in TB. In the mouse 
model, Maglione et al. found low dose Mtb aerosol infection of B cell deficient mice had similar 
bacterial levels to wild type mice, but did not form follicles and had disrupted pulmonary 
architecture 
77
. However, higher bacterial challenge resulted in exacerbated pathology with 
increased neutrophil infiltration and significantly higher bacterial burden in the lung 
77
. In 
addition, Fcreceptor IIB-/- mice have a decreased bacterial burden in the lung and enhanced 
Th1 cellular responses 
245
. These data suggest that antibodies produced by B cells engage Fc 
receptors to modulate the Mtb immune response, in this case detrimentally 
245
. The specific 
function and contribution of B cells continues to be investigated. 
Recently, we have identified that ectopic lymphoid follicles containing CXCR5
+
 cells are 
found within Mtb granulomas and formation correlates with protective immunity (as discussed in 
previous chapter). However, the mechanism of ELO formation and protective immunity against 
Mtb is uncertain. In this report, we show that CXCL13 recruits CXCR5
+
CD4
+
 T cells that are 
essential for ectopic lymphoid follicle formation within Mtb granulomas that mediate protective 
immunity. CXCR5
+
 B cells are also found within the Mtb-infected lung, but these cells did not 
increase in frequency and B cell deficient mice were not more susceptible to Mtb challenge. 
Further, CXCR5
+
CD4
+
 T cells were found to produce the highest levels of Th1 proinflammatory 
cytokines and to localize near Mtb-infected macrophages driving activation and bacterial killing. 
Finally, the typical Tfh driving cytokines, IL-6 and IL-21, were required for optimal ectopic 
follicle formation, but not needed for protection. Our data prove that ectopic lymphoid follicle 
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formation in the granuloma is driven by CXCL13 and protective immunity is ascribed to Th1 
cytokine producing CXCR5
+
CD4
+
 T cells. 
3.3 MATERIALS AND METHODS 
3.3.1 Mtb Infection in Mice 
C57BL/6 (B6), Il6
-/-
, µMT
-/-
 (B cell deficient mice), Cxcl13
-/-
 and Cxcr5
-/-
 mice on the B6 
background were purchased from The Jackson Laboratory, Bar Harbor, ME.  Il21
-/-
 mice were 
obtained from the Mutant Mouse Regional Resource Center (MMRC) and backcrossed to B6 
mice for 10 generations. ESAT-6 (Early Secreted Antigenic Protein 6)  TCR transgenic  (Tg) 
mice recognize IA
b
/ESAT-61-20 and were kindly provided by Dr. G. Winslow (Wadsworth 
Center, Albany, NY) and Dr. D. Woodland (Trudeau Institute, Saranac Lake, NY)
43
. The ESAT-
6 TCR Tg mice were crossed and maintained on the Rag1
-/-
 background. All mouse strains were 
bred and maintained at the Children’s Hospital of Pittsburgh’s animal facility. Experimental 
mice were age-and sex-matched and used between the ages of 6-8 wks in accordance with 
University of Pittsburgh International Animal Care and Use Committee guidelines. Mtb strain 
H37Rv was cultured in Proskauer Beck medium containing 0.05% Tween 80 to mid-log phase 
and frozen in 1 ml aliquots at -70
o
C.  Animals were aerosol infected with ~100 (low dose ) or 
~1000 (high dose) Colony Forming Units (CFU) of bacteria using a Glas-Col airborne infection 
system 
227
.  At given time points, organs were harvested, homogenized and serial dilutions of 
tissue homogenates plated on 7H11 plates and CFU determined. In some experiments, mice were 
subcutaneously vaccinated with ESAT61-20 peptide (400 mg) emulsified with the adjuvant 
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containing MPL with TDM (Sigma-Aldrich) and DDA (ACROS organics) as described before 
135
. On day 14 post vaccination, splenic CD4
+
 T cells were sorted and cultured with irradiated 
APCs and Th polarizing conditions as described below. For generation of Th cell subsets, naïve 
ESAT-6 Tg CD4
+
 T cells were cultured with BMDCs, ESAT61-20 peptide and cytokine cocktails. 
Tfh cells were cultured in Iscove’s complete medium containing IL-21 (50ng/ml), anti-IL-4 
(10g/ml), anti-IFN (10g/ml), and IL-2 (10U/ml); Th1 cells were cultured in complete DMEM 
containing IL-12 (10ng/ml), anti-IL-4 (10μg/ml) and IL-2 (10U/ml) 246. Further, B6 mice were 
aerosol infected with ~100 cfu Mtb H37Rv and beginning at day 15 post infection, mice received 
200 µg anti-CXCL13 antibody or isotype control antibody (R&D Biosystems) every other day 
until day 30 post infection on which organs were harvested. 
3.3.2 Mtb Infection In NHPs 
NHPs were infected as previously described in Section 2.3.2. 
3.3.3 Lung and Spleen Single Cell Preparation 
Lung tissue and the spleen were prepared as previously described 
45
. Briefly, single cell 
suspensions were prepared from digested lung tissue or spleen by dispersing the tissue through a 
70µm nylon tissue strainer (BD Falcon, Bedford, MA). The resultant suspension was treated 
with Gey’s solution to remove residual red blood cells, washed twice, counted and used in assays 
described below.  
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3.3.4 Flow Cytometry 
Single cell suspensions were stained with fluorochrome-labeled antibodies specific for CD3 ( 
145-2C11), CD4 (RM4-5), CXCR5 (2G8), IFN (XMG1.2), TNF (MP6-XT22), IL-21 (IL-
21R-FC chimeric protein), IL-2 (JES6-5H4), Tbet (04-46) CD44 (IM7), Gr1 (RB6-8C5), CD11c 
(HL3), CD11b (M1/70), B220 (RA3-6B2), CD19 (ID3), Ly77 (GL7), CXCR3 (173), Bcl6 
(7MG191E), ICOS (7E.17G9), PD-1(J43) and PNA (Sigma) or relevant isotype control 
antibodies. For intracellular analyses of cells, cells stimulated with phorbol myristate acetate 
(PMA-50ng/ml), ionomycin (750 ng/ml; Sigma Aldrich) or ESAT61-20 peptide (5 μg/ml) and 
Golgistop (BD Pharmingen), were surface stained, permeabilized with Cytofix-Cytoperm 
solution (BD Pharmingen) and stained for relevant cytokines. Cells were read using a Becton 
Dickinson FACS Aria flow cytometer using FACS Diva software. Cells were gated based on 
their forward by side scatter characteristics and the frequency of specific cell types was 
calculated using FlowJo (Tree Star Inc, CA). The mean fluorescent intensity was also calculated 
to determine expression levels of different molecules using FlowJo (Tree Star Inc, CA). 
3.3.5 CXCL13 In Situ Hybridization 
Performed as described in Section 2.3.5. 
3.3.6 Morphometric Analysis and Immunofluorescence 
Processing and staining was performed as mentioned in Section 2.3.4. Further, inducible NO 
Synthase (goat anti-mouse, M-19; Santa Cruz Biotechnology) and F4/80 (MCA497GA, Serotec) 
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were used. Primary Abs were detected with secondary Ab conjugated to Alexa fluor 568 for 
iNOS (Alexa fluor 568, donkey anti goat, Invitrogen). 
3.3.7 Real-Time PCR 
RNA was extracted as previously described 
247
.  RNA was treated with DNAse and reverse 
transcribed and cDNA was then amplified with FAM-labeled probe and PCR primers on the ABI 
Prism 7700 detection system. The log10 fold-induction of mRNA in experimental samples was 
calculated over signals derived from uninfected/control samples. The specific gene expression 
was calculated relative to GAPDH expression. The primer and probes sequences targeting genes 
encoding iNOS have been previously published 
24
. 
3.3.8 Detection of IFN--Producing Cells by ELISPOT Assay 
ESAT-61-20-specific IFN--producing IA
b
-restricted T cells from infected lungs or spleen were 
enumerated using peptide-driven ELISpot as described 
45
.  Briefly, 96 well ELISpot plates were 
coated with monoclonal anti-mouse IFNblocked with media containing 10% FBS. Cells from 
lungs and spleen were seeded at an initial concentration of 5x10
5 
cells/well and subsequently 
diluted two fold.  Irradiated B6 splenocytes were used as APCs at a concentration of 1x10
6
 
cells/well in the presence of ESAT-61-20 (10g/ml) peptide and IL-2 (10U/ml). After 24 hrs, 
plates were washed and probed with biotinylated anti-mouse IFN. Spots were visualized and 
enumerated using a CTL-Immunospot S5 MicroAnalyzer.  No spots were detected in cultures 
lacking antigen or when using cells from uninfected mice. 
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3.3.9 Protein Estimation by ELISA 
Mouse Duoset ELISA antibody pairs from R&D Systems were used to detect IFN and IL-21 
protein levels in the supernatant according to manufacturer’s protocol. In some experiments 
protein levels were measured using a mouse Luminex assay (Linco/Millipore). 
3.3.10 Adoptive Transfer of CD4+ Cells 
Naive CD4
+
 T cells were isolated from single cell suspensions generated from lymph nodes and 
spleens of ESAT-6 TCR Tg mice, B6 and Cxcr5
-/- 
mice using a positive CD4
+
 T cell isolation kit 
(Miltenyi Biotech) as described 
24
. For adoptive transfer into host mice, 2-5 x 10
6
 naïve T cells 
were transferred intravenously, following which mice were rested for 24 hours and challenged 
with Mtb H37Rv by the aerosol route.  
3.3.11 CXCL13 Chemotaxis Assay 
B6 mice were aerosol infected with 100 cfu Mtb and sacrificed at day 50 post infection. Using a 
positive CD4+ T cell isolation kit (Miltenyi Biotech), CD4+ T cells were isolated and 1x10
5
 cells 
were placed in 24 well transwell plate for chemotaxis assay to CXCL13 (500 ng/ml). CD4+ T 
cells were allowed to migrate for 90 minutes when they were stained with antibodies specific for 
CD4, ICOS, IFNand BCL-6. Wells that did not contain CXCL13 were used as controls. 
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3.3.12 Statistics 
Differences between the means of experimental groups were analyzed using the two tailed 
Student’s t-test.  Differences were considered significant when p≤0.05.   
3.4 RESULTS 
3.4.1 Activated CD4+CXCR5+ T cells accumulate in the lung during Mtb infection  
Given that ectopic lymphoid structures associated with TB granulomas contained CXCR5
+
 T 
cells, we next tested whether these cells were functionally important. The accumulation of 
activated, IFN-producing CD4+ T cells normally occurs in the murine lung between days 15-21 
following low dose Mtb infection 
51, 80
. We found activated, CD4
+ 
CXCR5
+
 T cells also 
accumulated in the lungs between days 15-21 (Figure 8a). Notably, a higher frequency and 
number of CXCR5
+
 T cells was found in the activated CD44
hi 
CD4
+
 T cell subset when 
compared to unactivated naive CD4
+
 CD44
lo
 T cell subset (Figure 8b).  In contrast, although a 
population of lung B cells also expressed CXCR5; this population did not increase in frequency 
following Mtb infection (Figure 8c). Furthermore, B cell deficient mice are not susceptible to 
low dose Mtb infection 
76-77
, suggesting that CD4
+
 CXCR5
+
 T cells, rather than CXCR5
+
 B cells, 
play a dominant role in protective immunity in the low dose model of Mtb infection. In addition, 
lung activated CD4
+
 CXCR5
+ 
T cells expressed significantly higher levels of Tfh-like cell 
markers, ICOS and PD1, when compared to activated CD4
+ 
CXCR5
-
 T cells and unactivated 
naive CD4
+
 T cells (Figure 8d). 
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Figure 8: Activated CD4
+
 CXCR5
+
 T cells accumulate in the lung during Mtb infection and express both Tfh-
like markers.  
 
B6 mice were infected as in Figure 6. The frequency and number of activated CD4+ CXCR5+ T cells and 
B220+CD19+CXCR5+ B cells was determined by flow cytometry at different time points post infection (a,c). 
Frequency and number of activated (CD44hi) and unactivated (CD44lo) CD4+ CXCR5+ T cells were determined in 
Mtb-infected lungs on day 25 post infection by flow cytometry (b). A typical histogram showing CXCR5 specific 
staining (filled) within activated CD4+ T cells and relevant isotype control antibody (open) is shown (b). Expression 
of ICOS and PD-1 (d) on activated (CD44hi) and unactivated (CD44lo) CD4+ CXCR5+ and CD4+ CXCR5- T cells 
were calculated by determining the mean fluorescent intensity using flow cytometry. A typical histogram showing 
expression of PD1 and ICOS (filled) and relevant isotype control antibody (open) on activated CD4+ CXCR5+ cells 
is shown (d). The data points represent the mean (±SD) of values from 4-6 mice. (a-e). *p=0.05, ***p=0.0005. ns- 
not significant. One experiment representative of two. 
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3.4.2 Pulmonary CD4+CXCR5+ T cells produce proinflammatory cytokines 
Importantly, we found that ICOS
+
 PD1
+
 CD4
+
 T cell population was increased during infection 
(Figure 9a) and were enriched for expression of CXCR5 and CD44 (Figure 9b). As expected 
248
, 
activated CD4
+ 
CXCR5
-
 T cells also expressed ICOS and PD-1, albeit at reduced levels (Figure 
8d). Interestingly, activated CD4
+ 
CXCR5
+
 T cells also expressed the highest levels of the 
proinflammatory cytokines IFN, TNF and IL-2 (Figure 9c), individually, or in combination 
and cytokine-production by CXCR5
+
 T cells was Mtb-specific (Figure 10a, b). However, only a 
small population of CD4
+ 
CXCR5
+
 T cells produced IL-17 and IL-21 (Figure 10a). Despite 
increased expression of proinflammatory cytokine production in activated CD4
+ 
CXCR5
+
 T 
cells, there were no differences in overall percentage (Figure 10a) or numbers of cytokine-
producing cells between activated CD4
+
 CXCR5
+
 and CD4
+
 CXCR5
-
 T cells. In addition, CD4
+
 
CXCR5
+
 population expressed higher levels of Bcl6, while expressing similar levels of Tbet as 
CD4
+ 
CXCR5
-
 T cell populations (Figure 10c). These data together suggest that activated CD4
+ 
T cells express markers characteristic of Tfh-like cells such as ICOS, PD-1 and Bcl6, but also 
exhibit markers of Th1-like cells such as production of proinflammatory cytokines and 
expression of Tbet. 
3.4.3 CD4+CXCR5+ T cells coexpress the chemokine receptor, CXCR3 
We then determined if activated CD4
+
 CXCR5
+
 T cells expressed other chemokine receptors 
such as CXCR3, which are associated with Mtb-induced lung inflammatory T cell accumulation 
136
. We detected expression of CXCR3 on a population of activated CD4
+
 T cells (Figure 11a) 
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Figure 9: Pulmonary CD4
+
 CXCR5
+
 T cells produce proinflammatory cytokines. 
On day 25 post infection, organs from uninfected (Un) and infected (Inf) B6 mice were assessed for the percentage 
or number of ICOS+ PD1+ within CD4+ T cells by flow cytometry (a). The expression of CD44 and CXCR5  and 
number of CD44+ CXCR5+ T cells within ICOS+PD1+ gate (R1) or ICOS-PD1- gate (R2) was calculated (b). 
Expression of IFNg, TNFa and IL-2 (c) on activated (CD44hi) and unactivated (CD44lo) CD4+ CXCR5+ and CD4+ 
CXCR5- T cells were calculated by determining the mean fluorescent intensity using flow cytometry. The data 
points represent the mean (±SD) of values from 4-6 mice. (A-D). **p=0.005, ***p=0.0005. One experiment 
representative of two. 
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Figure 10: Pulmonary CD4
+ 
CXCR5
+
 T cells produce proinflammatory cytokines. 
On day 25 post infection, organs from uninfected (Un) and infected (Inf) B6 mice were assessed for the percentage 
of cytokine producing cells within CD44hi CXCR5+ and CD44hi CXCR5- was determined after stimulation with 
PMA/Ionomycin for 5 hours followed by intracellular staining and flow cytometry (a). A typical contour plot 
showing cytokine specific staining (left panel) within activated CD4+ CXCR5+ T cells and relevant isotype control 
antibody (right panel) shown. Cells from day 25 Mtb-infected lungs were stimulated with ESAT6 peptide and 
expression of CXCR5 was determined on CD44 hi IFN+TNF+ cells (b). Expression of Tbet and Bcl6 (c) on 
activated (CD44hi) and unactivated (CD44lo) CD4+ CXCR5+ and CD4+ CXCR5- T cells were calculated by 
determining the mean fluorescent intensity using flow cytometry.The data points represent the mean (±SD) of values 
from 4-6 mice. (a-c). **p=0.005, ***p=0.0005. One experiment representative of two. 
 
 61 
and found that a subset of CXCR3
+
 CD4
+
 T cells also co-expressed CXCR5 (Figure 11b). 
Surprisingly, we found that the CD4
+ 
CXCR5
+ 
T cell subset expressed the highest frequency and 
expression levels of IFN c) and other proinflammatory cytokines, when compared 
to activated CD4
+ 
CXCR3
+
 or CD4
+ 
CXCR3
+ 
CXCR5
+
 T cell populations within Mtb-infected 
lungs (Figure 11c). Furthermore, in contrast to the localized expression of CXCL13 mRNA 
observed within lymphoid follicles (Figure 7 a, b), we found that mRNA for CXCL9, a CXCR3-
ligand, was localized both within the inflammatory lesions as well as near blood vessels in the 
Mtb-infected murine lung (Figure 11d) and latently infected NHPs (Figure 11e). These data 
together suggest that Mtb-induced inflammatory chemokines such as CXCL9 are expressed near 
blood vessels and likely recruit activated CD4
+
 T cells to the lung, but that CXCR5-CXCL13 
interactions may be specifically required to localize potent cytokine-producing CD4
+
 T cells 
within the lung parenchyma to organize lymphoid follicles and maximize mycobacterial control 
within granulomas.   
3.4.4 CXCR5 expression is required for protective immunity against Mtb infection 
To determine if there was a protective role for CXCR5 in immunity against TB, CXCR5-
deficient (Cxcr5
-/-
) mice were infected with Mtb and found to harbor higher lung bacterial 
burdens during early and chronic stages of infection, when compared to B6 mice (Figure 12a). In 
addition, CXCL13 neutralization also resulted in increased bacterial burden (Figure 12a) and 
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Figure 11: CD4
+
 CXCR5
+ 
T cells also coexpress the chemokine receptor, CXCR3. 
B6 mice were infected as in Figure 6 and lungs were harvested on day 25 post infection. The expression of CXCR3 
(a), CXCR3 and CXCR5 (b) on activated CD4+ cells was determined by flow cytometry. A typical histogram with 
CXCR3 specific staining (filled) and relevant isotype control antibody within activated CD4+ T cells is shown 
(open) (a). A typical contour plot showing co-expression of CXCR3 and CXCR5 on activated CD4+ T cells is 
shown (b). The frequency and mean fluorescent intensity of IFN expression within activated CD4+ CXCR5+, 
CXCR5+CXCR3+ and CXCR3+ T cells was determined in cells stimulated with PMA/Ionomycin for 5 hours 
followed by intracellular staining and flow cytometry (c). The data points represent the mean (±SD) of values from 
4-6 mice. (a-c). Lung FFPE serial sections were analyzed by ISH to determine localization of CXCL9 or CXCL13 
mRNA expression in murine (d) or L-TB NHP (e). Black arrows point to mRNA localization within the lung 
parenchyma, while red arrows point to mRNA localization near blood vessels.  *p=0.05, **p=0.005. Original 
magnification 100x. One experiment representative of two. 
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both Cxcr5
-/- 
and Cxcl13
-/- 
mice demonstrated decreased survival in response to high dose Mtb 
infection (Figure 12b). Using the low dose Mtb infection model, we found that the accumulation 
of total B cells (Figure 12c) was similar in B6 and Cxcr5
-/-
 Mtb-infected lungs, while Cxcr5
-/- 
Mtb-infected lungs showed impaired accumulation of lung GC B cells (Figure 12d). 
Furthermore, no differences in levels of ESAT-6-specific IgG1, IgG2a and IgG2b antibodies 
were found in B6 and Cxcr5
-/-
 Mtb-infected mice. Therefore, we next assessed T cell responses, 
and found that despite lack of mediastinal lymph nodes and defective splenic architecture in 
Cxcr5
-/-
 mice 
249
, comparable percentages of IFNproducing CD4+ cells (Figure 12 g, h) and 
number of Mtb-ESAT-6-specific, IFN-producing CD4+ cells (Figure 12e, f) were found in the 
lungs and spleen of Cxcr5
-/-
 and B6 Mtb-infected mice. In addition, neither differences in 
frequency of total CD4
+
 T cells producing TNF and IL-2, nor differences in  expression levels 
of IFNTNF and IL-2 within CD4+ T cells were observed in B6 and Cxcr5-/- Mtb-infected 
lungs. The percentage of CD4
+
 T cells expressing Tfh-like cell markers ICOS and PD1 (Figure 
13a), and the ability of activated ICOS
+ 
PD1
+
 Th cells to produce IFN (Figure 13b), TNF and 
IL-2 was also similar in B6 and Cxcr5
-/-
 Mtb-infected lungs. To then address if Cxcr5
-/-
 T cells 
had the potential to differentiate into cytokine-producing Th cell subsets, we immunized B6 and 
Cxcr5
-/-
 mice with ESAT6 peptide in adjuvant and expanded splenic CD4
+
 T cells in vitro in the 
presence of Th1 or Tfh cell differentiation conditions. Similar to B6 CD4
+
 T cells, Cxcr5
-/-
 CD4
+
 
T cells produced IFNin response to Th1 polarizing conditions (Figure 13c) and produced IL-21 
in response to Tfh cell differentiation conditions (Figure 13d). These data suggest that in the 
absence of CXCR5, B cells and cytokine producing antigen-specific T cells accumulate 
efficiently in the Mtb-infected lung.   
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Figure 12: CXCR5 expression is required for protective immunity against Mtb infection.   
B6 and Cxcr5-/- mice were infected or B6 Mtb-infected mice received CXCL13 neutralizing antibodies and lung 
bacterial burden determined  (a). Survival of B6, Cxcl13-/- and Cxcr5-/- mice with high dose (1000 CFU) of  
aerosolized Mtb infection was determined (b). The number of total B cells (B220+ CD19+) (c) or GC B cells 
(B220+, CD19+, PNA+, and Ly77+) (d) was determined by flow cytometry in B6 and Cxcr5-/- Mtb-infected lungs 
on day 21 post infection. The total percentage of IFN producing CD4+ T cells in the lung (e) and spleen (f) were 
determined by intracellular staining and flow cytometry after stimulation with PMA/Ionomycin for 5 hours ex vivo. 
The number of ESAT-6 specific IFN-producing CD4+ T cells were determined in the lung (g) and spleen (h) by 
antigen-driven ELISpot assay. The data points represent the mean (±SD) of values from 4-6 mice. (a-h). *p=0.05, 
**=0.005, ***p=0.0005. One experiment representative of two. 
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Figure 13: CXCR5 expression is not required for accumulation of cytokine-producing ICOS
+
 PD1
+
 T cells 
during Mtb infection. 
 
B6 and Cxcr5-/- mice were infected as in Figure 3. The percentage of CD4+ T cells expressing ICOS and PD1 (a) 
and CD4+ ICOS+ PD1+ cells expressing IFN (b) was determined by intracellular staining with PMA/Ionomycin. 
B6 and Cxcr5-/- mice were subcutaneously vaccinated with ESAT61-20 peptide in adjuvant and on day 14 post 
vaccination, splenic CD4
+
 T cells were cultured in vitro along with irradiated APCs and antigen under Th1 or Tfh 
cell differentiation conditions for 6 days as described in methods. At the end of the culture period, the CD4
+
 T cells 
were re-stimulated with beads coated with anti-CD3/CD28 for 24 hours and culture supernatants assayed for IFN 
(c) or IL-21 (d) by ELISA. The data points represent the mean (±SD) of values from 4-6 mice (a-d). ns-not 
significant. One representative of two experiments is shown. *p=0.05. ns=not significant. 
 
We therefore next addressed if the increased susceptibility in the Cxcr5
-/-
 mice was due to 
defects in localization of T cells within lung inflammatory lesions.  In support of a role for 
CXCR5 in correct T cell localization inside granulomas, CD3
+
 T cells were dispersed throughout 
the organized lung granulomas in the B6 Mtb-infected mice (Figure 14a-upper panel). However, 
CD3
+
 T cells were found as distinct perivascular cuffs in Cxcr5
-/-
 Mtb-infected lungs  and B6 
mice that received CXCL13 neutralizing antibody (Figure 14b-lower panel, Figure 14c), 
resulting in disrupted granuloma formation (Figure 14a-lower panel) and defective lymphoid 
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structure generation (Figure 14d, e). These data together suggest that the increased susceptibility 
to Mtb infection seen in the Cxcr5
-/- 
mice, is not due to impaired priming, generation or 
accumulation of cytokine-producing Tfh-like cells in the Mtb-infected lungs, but due to the 
inability of cytokine-producing CD4
+
 T cells to localize correctly within the Mtb-infected lung, 
and therefore unable to activate local macrophages to control Mtb.  
3.4.5 B cell deficient mice localize T cells within the granuloma and control Mtb 
We next addressed whether B cell lymphoid follicle formation within TB granulomas was a 
consequence of correct T cell localization and therefore a correlate of protection, but by itself not 
necessary for mediating the immune protection in Mtb-infected mice. We found that Mtb-
infected B cell deficient mice (μMT-/-) despite exhibiting disrupted granuloma formation and 
poorly formed lymphoid follicles in the lungs (Figure 15a-left panel), still controlled infection 
(Figure 15b) as previously described 
76-77
. In addition, B cell deficient Mtb-infected mice 
generated and recruited similar numbers of ICOS
+ 
PD1
+ 
CXCR5
+ 
T cells and accumulated 
similar numbers of antigen-specific IFN-producing cells to the lung (Figure 15c). Furthermore, 
immune control in B cell deficient mice coincided with well dispersed T cells localized in the 
inflammatory lesions in the lungs (Figure 15a-center panel) and resultant macrophage activation 
(Figure 15a-right panel, Figure 15d).  These data together suggest that B cells are not required 
for bacterial control and T cell localization in the mouse.  Further, that B cells are not required 
for macrophage activation, but that it is indeed T cell localization near Mtb-infected 
macrophages and the formation of ectopic follicles that is critical for host protective immunity.  
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Figure 14: CXCR5 expression is required for ectopic lymphoid follicle formation during TB.   
 
B6 and Cxcr5-/- mice were infected or B6 Mtb-infected mice received CXCL13 neutralizing antibodies. At day 50 
post infection, FFPE lung sections were H&E stained or analyzed by immunofluorescence for CD3, B220 (a,b); 
Representative pictures of granulomas (a) and perivascular T cell cuffing (b)  shown. Black and yellow arrows 
indicate T cell perivascular cuffing (b). Average area of perivascular cuffs was quantified using the the Zeiss 
Axioplan microscope (c). Error bars are not visible in day 30 B6 isotype group (c).  B cell lymphoid follicles were 
detected with PCNA, PNA, and B220 at  day 50 post infection (d). The average size of B cells follicles was 
quantified using the Zeiss Axioplan microscope (e). 100X magnification -H&E images; 200X magnification-
fluorescent images. The data points represent the mean (±SD) of values from 4-6 mice (a-e).  One representative of 
two experiments is shown. **p=0.005, ***p=0.0005. ns=not significant. 
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Figure 15: B cell deficient mice localize T cells within the granuloma and control Mtb.   
B6 and MT-/- mice were infected as described in Figure 6 and FFPE lung sections were stained with H&E or  
analyzed using antibodies specific for CD3 and iNOS, F4/80 (a); Representative pictures are shown. 50X 
magnification-H&E images, 200X magnification-fluorescent images.  At day 50 post infection, bacterial burden was 
determined in the lung  (b). The number of ESAT-6 specific IFNproducing CD4+ T cells were determined in the 
lung by antigen driven ELISpot assay (c). Log10 fold induction of iNOS mRNA in B6 and MT-/- Mtb-infected 
lungs relative to levels in uninfected lungs was determined by RT-PCR (d).  The data points represent the mean 
(±SD) of values from 4-6 mice. (a-d). ns=not significant. One experiment representative of two. 
3.4.6 CD4+ T cells responsive to CXCL13 produce IFNand activatemacrophages
In support of a role for CXCR5-CXCL13 in T cell localization within the lung for optimal 
macrophage activation, we found that CD4
+
 T cells isolated from B6 Mtb-infected lungs 
migrated in response to CXCL13 in vitro, produced IFN -like cell markers, 
ICOS and Bcl6 (Figure 16a, b). Importantly, we found that despite similar numbers of lung 
macrophages and DCs in B6 and Cxcr5
-/-
 Mtb-infected lungs (Figure 16c, d), Cxcr5
-/-
 Mtb-
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infected lungs had reduced induction of mRNA for the anti-mycobacterial molecule, iNOS 
(Figure 16e), and fewer iNOS
+
 macrophage-like cells were detected within the disorganized 
granulomas of Cxcr5
-/-
 and Cxcl13 deficient (Cxcl13
-/-
) Mtb-infected lungs (Figure 16f). 
Furthermore, CD11c
+
 DCs and macrophages sorted from Cxcr5
-/-
 and Cxcl13
-/-
 Mtb-infected 
lungs, displayed lower iNOS mRNA expression, when compared to cells isolated from B6 Mtb-
infected lungs (Figure 16g). These data together suggest that expression of CXCR5 is critical for 
strategic positioning of effector T cells within the lung for optimal macrophage activation, 
subsequent organization of lymphoid follicles and Mtb control. 
3.4.7 Adoptive transfer of ESAT-6 Tg Th0 cells rescues Mtb-infected Cxcr5-/- mice 
Our data suggests that localization of CD4
+ 
CXCR5
+
 T cells within lymphoid structures is 
critical for generation of lymphoid structure formation, macrophage activation and mycobacterial 
immune control. Therefore, we determined if adoptive transfer of purified naïve ESAT-6-
specific transgenic (Tg) T cells 
43
 capable of expressing CXCR5, into Cxcr5
-/-
 mice would rescue 
T cell localization within the lung, macrophage activation and reverse susceptibility to TB. 
Cxcr5
-/-
 mice that did not receive ESAT-6 Tg Th0 cells had higher bacterial burden (Figure 17a), 
contained numerous lymphocytic perivascular cuffs (Figure 17b), defective lymphoid follicle 
generation and reduced numbers of activated macrophages (Figure 17c-middle panel). In 
contrast, B6 Mtb-infected mice formed ectopic lymphoid structures characterized by 
lymphocytic infiltrates (Figure 17b, c), B cell follicles and granulomas with considerable 
numbers of iNOS-expressing macrophages (Figure 17c-upper panel). Importantly, adoptive 
transfer of ESAT-6 Tg Th0 cells into Cxcr5
-/-
 mice decreased lung bacterial burden (Figure 17a), 
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Figure 16: CD4
+
 T cells responsive to CXCL13 produce IFN and are critical for macrophage activation. 
CD4
+
 T cells were sorted from day 21 Mtb-infected B6 lungs and assayed in vitro for chemotaxis migration assay 
towards CXCL13 (500 ng/ml). The ability of CD4
+
 T cells to produce IFNpre- and post-migration was determined 
by intracellular staining and flow cytometry in PMA/Ionomycin stimulated cells (a). A representative contour plot 
showing surface expression of Bcl6 and ICOS on CD4+ T cells that was determined by flow cytometry (b). B6 and 
Cxcr5-/- mice were infected as mentioned in Figure 6. The number of lung macrophages (c) and dendritic cells (d) 
were determined by flow cytometry on day 21 post infection. Log10 fold induction of iNOS mRNA in B6 and 
Cxcr5-/- Mtb-infected lungs relative to levels in uninfected lungs was determined by RT-PCR on day 21 post 
infection (e). FFPE lung sections from day 21 Mtb-infected B6, Cxcr5-/- and Cxcl13-/- mice were analyzed by 
immunofluorescence for number of iNOS+ cells per granuloma (f). On day 21 post infection, lung CD11c+ cells 
were isolated from uninfected or Mtb-infected B6, Cxcr5-/- and Cxcl13-/- mice. iNOS mRNA expression in 
CD11c+ cells isolated from infected mice over levels detected in uninfected controls was determined by RT-PCR 
(g). The data points represent the mean (±SD) of values from 3-6 samples (a-g).  *p=0.05, **p=0.005, p***=0.0005. 
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restored lung lymphocytic infiltrates, T cell localization, restored generation (Figure 17c) and 
organization of ectopic lymphoid follicles in Cxcr5
-/-
 mice (Figure 17b, c), and activation of lung 
macrophages (Figure 17c-lower panel). Tracking  of  congenic, CD90.2
+
 ESAT-6 Tg cells in 
Mtb-infected congenic CD90.1
+
 mice, revealed that adoptively transferred naive Tg Th0 cells 
had underwent activation and acquired the expression of CXCR5, ICOS, PD-1 and the ability to 
produce proinflammatory cytokines (Figure 17d). 
3.4.8 Adoptive Transfer of B6 but not Cxcr5-/- CD4+ T cells rescues Mtb-infected Cxcr5-/- 
mice 
To definitely prove that CXCR5 expression on CD4+ T cells was responsible of for the rescue of 
Cxcr5 deficient mice, Cxcr5-/- CD4
+
 T cells were utilized. We show that the increased bacterial 
burden (Figure 18a) and decreased lymphoid follicle organization (Figure 18b, c) and 
macrophage activation (Figure 18c, d) in Mtb-infected Cxcr5
-/- 
mice could only be reversed by 
adoptive transfer of CD4
+
 T cells isolated from B6 mice, but not by transfer of CD4
+
 T cells 
isolated from Cxcr5
-/- 
mice. These data together show that adoptive transfer of uncommitted Th0 
cells, capable of acquiring expression of CXCR5, restored strategic T cell localization within the 
lung, formation of lymphoid structures and reversed susceptibility to TB. 
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Figure 17: Adoptive transfer of ESAT-6 Tg Th0 cells rescues T cell localization and protection in Cxcr5-/- 
mice. 
 
2-5x10
6
 in vitro generated ESAT-6 Tg Th0 cells were adoptively transferred into Cxcr5-/- mice. 24 hours later, mice 
were infected as in Figure 6 and lung bacterial burden determined on day 50  (a). The average size of B cell 
lymphoid follicles was quantified in B6 and Cxcr5-/- Mtb-infected lungs on day 50  using the Zeiss Axioplan 
microscope (b). Pulmonary granuloma and B cell lymphoid follicle formation was assessed in FFPE lung sections 
that were stained with H&E; CD3, IgG, B220; CD3 alone; iNOS, F4/80 on day 50  (b,c). Original magnification for 
H&E sections, 50X; immunofluorescent sections, 200X. 2-5x10
6
 ESAT-6 Tg CD4
+ 
Th0 cells were adoptively 
transferred into congenic CD90.1 B6 mice and infected as in Figure 6. The frequency of cells expressing different 
molecules was determined in PMA/Ionomycin stimulated CD90.2 Tg cells isolated from infected lungs on day 21 
(d). The data points represent the mean (±SD) of values from 4-6 mice (a-d). *p=0.05, ***p=0.0005. ns-not 
significant. 
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Figure 18: Adoptive transfer of  B6, but not Cxcr5-/- CD4
+
 T cells, rescues T cell localization and protection in 
Cxcr5-/- Mtb-infected mice. 
 
2x10
6
 CD4
+
 B6 or Cxcr5-/- T cells were adoptively transferred into Cxcr5-/- mice. 24 hours later, mice were 
infected as in Figure 3 and lung bacterial burden determined on day 50 (a). The average size B cell lymphoid 
follicles was quantified in FFPE lung sections on day 50 using the Zeiss Axioplan microscope (b). Pulmonary 
granuloma and B cell lymphoid follicle formation was assessed in FFPE lung sections that were stained with H&E; 
CD3, IgG, B220; iNOS, F4/80 on day 50 (b,c). The number of iNOS
+ 
cells were quantitated using the Zeiss 
Axioplan Microscope (d). Original magnification for H&E sections, 50X; immunofluorescent sections, 200X. The 
data points represent the mean (+SD) of values from 4-6 mice (a-d). p**=0.005, ***=0.0005. 
 74 
3.4.9 IL-6 and IL-21 are required for optimal B cell lymphoid follicle formation, but are 
not essential for Mtb control 
IL-21 and IL-6 are required for polarization of Tfh cells 
237, 241, 246
. Coincident with the early 
accumulation of CD4
+
 CXCR5
+
 Tfh-like cells in Mtb-infected lungs, IL-6, IL-21, ICOS and PD1 
mRNA induction occurred in day 21-Mtb-infected lungs
80
 (Table 4). Therefore, we tested 
whether absence of IL-6 and IL-21 impacts protective immunity to TB and found that B cell 
follicle formation was reduced, but not absent, in Il21
-/-
 and Il6
-/-
 Mtb-infected lungs (Figure 19 
a,b,d,e) and did not impact lung bacterial control during Mtb infection (Figure 19 c, f) . These 
data suggest that although IL-6 and IL-21 are required for optimal generation of lymphoid 
structures, either IL-6 or IL-21 alone are sufficient for mediating protective immunity against 
TB.   
 
Table 4: Genes induced during murine TB are associated with generation of Tfh-like cellular responses 
80
.   
 
Fold induction of mRNA in Mtb-infected lungs over levels found in uninfected lungs shown. D-12, day 12 post 
infection; D-15, day 15 post infection; D-21, day 21 post infection. FC= fold change, q-val= q value. 
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Figure 19: IL-6 and IL-21 are required for optimal B cell lymphoid follicle formation, but are not essential 
for Mtb control.   
 
B6 and Il6-/- mice or B6 and Il21-/- mice were infected as in Figure 6. At day 50 post infection, FFPE lung sections 
were assessed for B cell lymphoid follicle organization  by immunofluorescence, 200X magnification (a, d).  The 
average size of B cell lymphoid follicles (b,e) and lung bacterial burden were determined at different time points 
post infection (c, d).  The data points represent the mean (±SD) of values from 4-6 mice (a-f).  ***p=0.0005. ns=not 
signigicant. 
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3.5 DISCUSSION 
We have previously shown that ectopic lymphoid follicles in granulomas are associated with 
immune control (previous chapter), but the mechanism of formation and protective immunity in 
Mtb infection remain unknown. Using the mouse model of TB, we identified two CXCR5 
expressing cell populations within the lung during Mtb infection, a CD4
+
 T cell and 
B220
+
CD19
+
 B cell. We show that CD4
+
CXCR5
+
 T cells are the critical cellular component of 
ectopic lymphoid follicles that contribute to protective immunity against TB. CD4
+
CXCR5
+
 T 
cells expressed a Tfh-like cell phenotype, while concurrently also expressing Th1 cytokines and 
surface markers. Our data prove that potent activated Th1 cytokine producing CXCR5
+
 Tfh-like  
cells localize to CXCL13 to position near Mtb-infected macrophages to activate and promote 
bacterial killing. Although, ectopic lymphoid follicle formation correlated with Mtb protective 
immunity, it was the recruitment of CD4
+
CXCR5
+
 T cells that specifically contributed to host 
defense against Mtb. Our results have far implications in the role of ectopic lymphoid follicles in 
infectious disease and autoimmunity. Further, these data has significant implications for future 
therapies and vaccine design against TB. 
Using Cxcr5 deficient mice, we found that expression of CXCR5 on T cells is not 
required for recruitment of T cells to the Mtb-infected lung, but is essential for T cell localization 
in the parenchyma near infected macrophages. Importantly, localized CD4
+
CXCR5
+
 T cells were 
required for macrophage activation and Mtb control in Cxcr5 deficient mice. The Cxcr5-/- 
phenotype is unique in that these mice lack the majority of lymph nodes and have defective 
splenic architecture 
249
. Despite the absence of lymph nodes, mice demonstrated no defects in T 
cell priming with similar numbers of Mtb-specific Th1 cytokine producing CD4
+
 T cells in the 
lung, which is consistent with previous reports in other antigen models 
250
. Further, similar 
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findings in SLO deficient B6 mice, which are still able to control Mtb, and Ccr7-/- mice show 
adaptive T cell responses that prime in the lung 
148, 251
. Cxcr5 deficient mice did not affect the 
number of ICOS
+
PD-1
+
 or CXCR3
+
CD4
+
 T helper cells arriving in the lung or the production of 
proinflammatory IFN and TNF levels further substantiating that CXCR5 does not affect Tfh 
or Th1 effector expression. However, Cxcr5-/- mice did exhibit reduced activation determined by 
iNOS expression with similar numbers of myeloid cells in the lung suggesting T cell localization 
mediated by CXCR5 is necessary for myeloid cell activation and Mtb control. Importantly, mice 
that received Mtb-antigen specific CD4
+
 T cells or wild type CD4
+
 CXCR5 expressing T cells 
were able to rescue T cell localization, macrophage activation, ectopic lymphoid follicle 
formation, and bacterial control suggesting that it is indeed the CXCR5 expression on CD4
+
 T 
cells that confers protective immunity in ectopic lymphoid follicles. This mechanism is likely 
conferred by localization of Th1 cytokine producing CD4
+
CXCR5
+
 T cells near Mtb-infected 
macrophages inducing activation and bacterial control. It is further possible that CXCR5 
expressing T cells also regulate adhesion molecules and chemokine expression by other 
inflammatory cells inducing cellular organization, which should be further investigated.  
It is becoming clear that some T helper cell phenotypes maintain a degree of plasticity 
63, 
252-253
. Although in vitro generated Tfh cells typically produce classic Tfh cytokines, namely IL-
21, and lineage specific transcription factors (BCL-6), in vivo generated Tfh cells can co-express 
multiple transcription factors in addition to BCL-6 and produce IFN, IL-4, and IL-17a 237, 241, 246, 
254-256
. Therefore, it appears Tfh cells are heterogeneous becoming either Th1/Th2/Th17 cells that 
are recruited to the B-T cell border for help and induction of class-switching in B cells or 
possibly being driven towards a lineage-specific phenotype in response to antigen stimulation. 
Tfh cells were driven towards a Th1 phenotype in response to immunization with a protein 
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antigen in adjuvant 
257
 and infection with Leishmania major 
256
 and Toxoplasma gondii 
258
 
inducing class switching to IgG2a. In addition, in response to Th2 driving pathogens, 
Schistosoma mansoni 
259
 and Heligmosomoides polygyrus 
255
 drove generation of IL-4 producing 
Tfh cells. Recently, studies found that Tfh cells share a transition stage with Th1 cells through 
STAT4, which induced the expression of T-bet concomitantly with BCL-6 
258
. Cells were 
therefore capable of expressing dual lineage characteristics and functionalities. Our data support 
this model, as CD4
+
 T cells generated during Mtb infection coexpressed both markers of Th1 and 
Tfh cells to become the highest producer of pro-inflammatory cytokines that were crucial for 
mediating protective immunity. Protective immunity produced by Th1 cytokine producing 
CD4
+
CXCR5
+
 T cells is consistent with studies showing that defense against Mtb is mediated by 
proinflammatory cytokines and CD4
+
 T cells that can produce multiple Th1 cytokines  
51, 106
.  
Expression of CXCR3 can also be found on a subset of CD4
+
CXCR5
+
 T cells. CXCR3 is 
a chemokine receptor normally associated with localization of Th1 cells and accordingly 
multiple CXCR3 ligands, CXCL9, CXCL10, and CXCL11 are induced in the Mtb-infected lung 
35, 133, 260-262
. It is possible that CD4
+
CXCR5
+
CXCR3
+
 T cells use CXCR3 and other chemokine 
receptors to get to the lung and use CXCR5 to position within the parenchyma near Mtb-infected 
macrophages for activation. Thus, it is tempting to speculate that CXCR3 may be down regulated 
upon arrival to the lung generating a CXCR5
+
CD4
+
 T cell population. Consistent with 
hypothesis, Cxcr3-/- are not more susceptible to Mtb infection, however, Cxcr5-/- and Cxcl13-/- 
have higher bacterial burdens and decreased macrophage activation with in the lung 
24, 136
. 
Further, CCR2 
263
, CCR5 
264
, and CCR7 
148
 deficient mice, chemokine receptors also expressed 
on T cells during Mtb infection, are also not more susceptible to low dose Mtb infection 
suggesting that redundancy in chemokine expression allow for CD4
+
 T cells to arrive to the lung, 
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but only CXCR5 expression is indispensable for localization of CD4
+
 T cells near infected 
macrophages. 
The role of B cell effector functions and antibody responses in Mtb protective immunity 
is a ongoing area of study as some reports suggest B cells are not essential for protection, while 
others refute this claim. B cells are a principal component of the Mtb-infected lung with B cell 
aggregates observed in human TB granulomas 
11, 79, 223
, A-TB NHP granulomas 
78
, and Mtb-
infected mouse granulomas 
24, 147
. Recently, B cell deficient mice in a low dose aerosol model of 
Mtb infection controlled bacteria in the lung 
77
, which we also found in our low dose mouse 
model. Further, these mice had similar levels of macrophage activation compared to wild type 
mice. Importantly, although these mice did not form ectopic lymphoid follicles, they were still 
able to localize CXCR5
+
CD4
+
 T cells within the parenchyma. In addition, adoptive transfer of 
B6 T cells expressing CXCR5, but not Cxcr5-/- T cells were able to rescue ectopic lymphoid 
follicle formation, bacterial burden, and macrophage activation in Cxcr5-/- mice. These data 
suggest that despite both T cell and B cell populations expressing CXCR5, it is the 
CXCR5
+
CD4
+
 T cells population that is responsible for protective immunity. Ectopic lymphoid 
follicles appear to form in response to correct T cell localization within the lung and can be used 
as a correlate of protection, but the structure itself may not be necessary for Mtb control. 
Determining the direct role of CXCR5
+
CD4
+
 T cells and ectopic lymphoid follicles in Mtb-
infected humans is a challenging task, but needs to be addressed to understand the potential use 
of these cells and markers in future treatment and prevention strategies. 
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4.0  PULMONARY CXCL13 PRODUCTION DURING M. TUBERCULOSIS 
INFECTION 
4.1 ABSTRACT 
CXC chemokine ligand (CXCL)-13 is constitutively expressed in SLOs and is induced in the 
lung during M. tuberculosis infection. Localization of CXCL13 is confined within distinct 
ectopic lymphoid follicles near the granuloma. Although it is known that follicular dendritic cells 
and other stromal cells produce CXCL13 in the lymph node, the cellular source of CXCL13 in 
early and late TB infection remains to be defined. We found in Mtb-infected mice that stromal 
cells, FDCs, and DCs within the lung produced CXCL13. To determine whether hematopoietic 
or non-hematopoietic cells contributed more to immune protection and whether production was 
similar in both early (day 30) and late (day 50) infection, Cxcl13 bone marrow chimeras were 
generated.  Mice deficient in Cxcl13 within non-hematopoietic cells were more susceptible early 
in infection, while both hematopoietic and non-hematopoietic cells producing CXCL13 were 
required for protective immunity in chronic Mtb infection. Further, non-hematopoietic Cxcl13 
deficient mice were unable to develop protective lymphoid follicles. Our data establish the 
importance of CXCL13 production in Mtb infection by both hematopoietic and non-
hematopoietic cell subsets. 
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4.2 INTRODUCTION 
CXCL13 is an 88 amino acid CXC-chemokine that was first discovered in 1998 and has 
sequence similarity to CXCL1, CXCL10, and CXCL12 although it performs a very different 
function 
151, 234
. CXCL13 is a homeostatic chemokine that is normally expressed within SLOs 
and is important for B cell follicle formation and polarization of the germinal center light and 
dark zones 
151, 234, 265
. Further, expression of CXCL13 is critical in ELO formation in certain 
autoimmune and infectious diseases indicating it is also an inducible chemokine (discussed in 
detail in Section 1.5). Initial production of CXCL13 in lymph node development is initiated by 
CD4
+
CD3
-
IL-7R+ lymphoid tissue inducer (LTi) cells 266-267. LTi cells express LTon their 
surface and engage the LTR on mesenchymal cells to produce homeostatic chemokines, such as 
CXCL13 
267-268
. Mesenchymal cells differentiate into a variety of cells types including follicular 
dendritic cells, the main producer of CXCL13 in the SLO, and other stromal cells 
172
. CXCL13 
then recruits CXCR5 expressing cells, mature B cells and Tfh cells, within the lymph node 
151, 
153, 234
. B cells participate in CXCL13 production by upregulated LT12  in response to the 
chemokine, which interacts with FDCs to further promote CXCL13 production 
152
. In addition, 
Tfh cells also appear to play a role in the production of CXCL13 as genome wide approaches 
have suggested the Cxcl13 gene is highly upregulated in this T cell lineage 
269-270
. Thus multiple 
cell types are responsible for CXCL13 production in SLO formation and maintenance. 
Other cell subsets have been implicated in the production of CXCL13 outside of SLOs, 
however, little is known regarding the production of CXCL13 in ELOs. In ectopic follicles of 
rheumatoid arthritis and ulcerative colitis patients, CXCL13 was produced by monocytes and 
macrophages, and FDCs 
192
. Further, in human blood DCs exposed to influenza virus, CXCL13 
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protein could be detected in supernatants in just 8 hours 
271
. In this study, we investigate the 
source of CXCL13 during Mtb infection in murine ectopic lymphoid follicles. We found that 
CXCL13 was produced by both hematopoietic and non-hematopoietic cells subsets, namely 
FDCs, non-FDC stromal cells, and DCs, but not lymphocytes. Further, we demonstrated that 
non-hematopoietic cell are critical for CXCL13 production early in Mtb infection while non-
hematopoietic and hematopoietic subsets both contribute later during infection. These data 
suggest that multiple stromal and myeloid cell subsets are necessary for pulmonary CXCL13 
induced ectopic lymphoid development in the Mtb-infected lung and that non-hematopoietic 
stromal cells are essential for early initiation.  
4.3 MATERIAL AND METHODS 
4.3.1 Mtb Infection in Mice 
Mice were infected as previously described in Section 3.3.1. 
4.3.2 Generation of Lung Cell Types 
For generation of lung fibroblasts, lungs were perfused with 5 units/ml dispase followed by 1% 
low melting agarose in PBS, washed in PBS and incubated in dispase for 30 minutes at 37
o
C.  
Single cell suspensions were then obtained from DNase/Collagenase treated lungs and 
fibroblasts generated by passaging 2-4 times. Lung alveolar macrophages were obtained by 
bronchoalveolar lavage as previously described 
247
. Lung CD11c
+
 cells were sorted from single 
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cell lung suspensions using a magnetically labeled CD11c positive isolation kit (Miltenyi 
Biotech, CA). Mouse tracheal epithelial cells (MTECs) were generated using an air-liquid 
interface culture as previously described 
272
. All the different cell types were stimulated with 
irradiated Mtb (100 g/ml) for 24 hours and cells supernatants analyzed for CXCL13 protein.  
4.3.3 Protein Estimation by ELISA 
Mouse Duoset ELISA antibody pairs from R&D Systems were used to detect CXCL13 protein 
levels in the supernatant according to manufacturer’s protocol. In some experiments protein 
levels were measured using a mouse Luminex assay (Linco/Millipore). 
4.3.4 Generation of Bone Marrow Chimeric Mice 
To generate chimeric mice, mice were given a medicated Sulfa-Trim diet containing 1.2% 
sulfamethoxazole and 0.2% trimethoprim (TestDiet) two weeks prior to irradiation. Mice were 
sub-lethally irradiated with 1000 rads in two doses (X-Rad 320). Mice were subsequently 
reconstituted with 10x10
6
 bone marrow cells from B6 or gene deficient mice via i.v. injection. 
Mice were allowed to reconstitute for 45 days while continuing to receive a Sulfa-Trim and 
acidified water diet following which they were used in experimental procedures. 
4.3.5 Morphometric Analysis and Immunofluorescence 
Immunofluorescence was performed as previously described in Section 2.3.4. In addition, DCs 
and stromal cells were stained with PE-hamster anti-mouse CD11c (HL3, BD Pharmingen) and 
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PE-mouse anti-mouse CD157 (BP3, BD Pharmingen). To amplify the signal, a rabbit, anti-PE 
antibody (Rockland Inc) was used, followed by its detection with Fab, donkey-anti rabbit-Cy3 
(Jackson Immunoresearch Laboratories). 
4.3.6 CXCL13 In Situ Hybridization 
Performed as previously described in Section 2.3.5. 
4.3.7 Statistics 
Differences between the means of experimental groups were analyzed using the two tailed 
Student’s t-test.  Differences were considered significant when p≤0.05.   
4.4 RESULTS 
4.4.1 CXCL13 is produced by hematopoietic and non-hematopoietic cells during Mtb 
infection 
Our data suggest that CD4
+ 
CXCR5
+
 T cells producing proinflammatory cytokines that 
accumulate in the lung respond to a pulmonary CXCL13 gradient. Accordingly, CXCL13 is 
known to be produced by DCs 
192, 273
, FDCs 
274-276
 and stromal cells 
277
 in SLOs. Following Mtb 
infection, we detected increased expression of CXCL13 protein in lung homogenates 
(uninfected: 42+/- 10.03 pg/ml, Mtb-infected: 452.96 +/- 82.3, p=0.001) and CXCL13 protein 
was found to co-localize with lung BP3
+ 
stromal cells, CD21-CD35
+
 FDCs and  CD11c
+
 DCs in 
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ELOs (Figure 20a). Furthermore, when lung alveolar macrophages, CD11c
+
 cells, mouse 
tracheal epithelial cells and fibroblasts were exposed to Mtb in vitro, CXCL13 protein was 
detected in supernatants from myeloid cells and fibroblasts, but not epithelial cell supernatants, 
suggesting that both hematopoietic and non-hematopoietic cells produce CXCL13 during Mtb 
infection (Figure 20b). Also, both CD11c
+
 and CD11c
-
 cells isolated from Mtb-infected B6 lungs 
expressed CXCL13 mRNA (Figure 20c). 
 
 
 
Figure 20: CXCL13 is produced by stromal and myeloid cells in Mtb infection. 
FFPE lung sections from B6 Mtb-infected mice were assessed for CXCL13-producing populations by 
immunofluorescence (a). Alveolar macrophages, lung CD11c+ cells, lung fibroblasts, and mouse tracheal epithelial 
cells (MTECs) were left untreated or treated with irradiated Mtb (100 mg/ml) for 24 hours and supernatants assayed 
for CXCL13 protein (b). ND-not detectable. CD11c+ and CD11c- cells were sorted from B6 Mtb-infected lungs 
(day 50 post infection) and log10 fold induction of CXCL13 mRNA relative to GAPDH was determined by RT-
PCR (c).  Immunofluorescence original magnification 200X. The data points represent the mean (±SD) of values 
from 3-4 samples (a-b) or from 4-6 mice (c). *p=0.05, **=0.005, ***p=0.0005. ns= not significant. One experiment 
representative of two is shown. 
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4.4.2 CXCL13 by different cell populations is critical in early and late Mtb infection 
To delineate the protective contributions of CXCL13 production by hematopoietic and non-
hematopoietic cells, we infected hematopoietic Cxcl13
-/-
 bone marrow chimeric (BMC) mice (B6 
host/-/- BM) or non-hematopoietic Cxcl13
-/-
 BMC mice (-/- host/B6 BM) with Mtb. As expected 
24
, complete Cxcl13
-/-
 BMC mice (-/-host/-/- BM) were more susceptible to Mtb infection than 
complete B6 BMC mice (B6 host/B6 BM) (Figure 21a). Interestingly, non-hematopoietic, but 
not hematopoietic Cxcl13
-/-
 BMC mice had increased lung bacterial burden at early time points 
(Figure 21a), while at later time points, both hematopoietic and non-hematopoietic Cxcl13
-/-
 
BMC mice had increased lung bacterial burden (Figure 21b), decreased T cell localization within 
the lung and reduced lymphoid structure formation when compared to B6 Mtb-infected lungs 
(Figure 21c, d). Furthermore, hematopoietic Cxcl13
-/-
 BMC mice which were protected during 
early infection, had more distinct T cell localization within the lung, highly organized B cell 
lymphoid follicle structures (Figure 21 c, d) and increased CXCL13 mRNA expression within 
lymphoid structures (Figure 21e). These data show that both hematopoietic and non-
hematopoietic sources of CXCL13 are required for lymphoid structure formation and protective 
immunity against Mtb infection, but that non-hematopoietic sources of CXCL13 are required for 
early protective immunity during TB. 
4.5 DISCUSSION 
Using the Mtb mouse model, we demonstrated that FDCs, non-FDC stromal cells, and DCs, all 
produce CXCL13 within pulmonary ectopic lymphoid follicles. However, we did not  
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Figure 21: CXCL13 is produced by hematopoietic and non-hematopoietic cells and required for Mtb control. 
Hematopoietic Cxcl13-/- BMC mice (B6 host/-/- BM), non-hematopoietic Cxcl13-/- BMC mice (-/- host/B6 BM), 
complete Cxcl13-/- BMC mice (-/- host/-/-BM) and complete B6 BMC mice (B6 host/B6 BM) were infected with 
Mtb and lung bacterial burden determined on day 30 (a) and day 50 (b). Pulmonary B cell lymphoid follicles were 
detected in FFPE lung sections (day 50) by immunofluorescent staining for CD3, IgG, and B220; DAPI (blue) was 
used to detect nuclei (c). Average size of the B cell lymphoid follicles was quantified using the Zeiss Axioplan 
microscope (day 50) (d). Day 30 FFPE lung sections were assayed for CXCL13 mRNA localization by ISH (e). 
Black arrows indicate CXCL13 localization within granulomas (e). ISH original magnification 600X. 
Immunofluorescence original magnification 200X. The data points represent the mean (±SD) from 4-6 mice (a-e). 
*p=0.05, **=0.005, ***p=0.0005. ns= not significant. One experiment representative of two is shown. 
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observe CXCL13 localization with any lymphocytic subset as implied by previous genome array 
studies 
269-270
. Further, in vitro data verified the capability of both stromal and myeloid cells to 
produce CXCL13 in response to Mtb. In addition, we characterized the importance of different 
cell subsets in the initiation of ectopic lymphoid follicle formation and we found that non-
hematopoietic subsets are essential for the earliest production of CXCL13 in the Mtb-infected 
lung as Cxcl13-/- non-hematopoietic bone marrow chimeric mice were unable to control 
infection and to form ectopic lymphoid follicles. However, later during infection (day 50), when 
inflammatory immune cells have infiltrated the lung, both non-hematopoietic and hematopoietic 
cell subsets contributed to ectopic lymphoid follicle formation and protective immunity against 
Mtb. Our data prove that different cellular sources of CXCL13 in ectopic lymphoid tissues can 
impact progression of disease and protective outcomes in chronic infections. Further, varying 
sources of CXCL13 ensure that CXCR5
+
 cells respond and migrate to the lung to elicit the 
highest protective immune response against Mtb. 
With our data and previous studies 
170, 184, 191, 194
, a likely mechanism of ectopic lymphoid 
follicle development unfolds. It is probable that either LTi cells or TNF and LT-induced by 
Mtb initiate production of CXCL13 in stromal cells. As infection progresses, FDCs and reticular 
networks develop further contributing to CXCL13 production. Further, inflammatory myeloid 
cells are recruited in large numbers to the lung, which also have the potential to produce 
CXCL13 later in infection. Upon formation of ectopic lymphoid follicles, B cells likely establish 
a positive feedback loop with FDCs promoting the maintenance of CXCL13 
152
, however, this 
help is dispensable in Mtb infection. Induction of CXCL13 further recruits a Tfh-like Th1 
proinflammatory producing CD4
+
CXCR5
+
 T cells that localizes near Mtb-infected macrophages 
promoting activation and bacterial killing and thus immune control in the lung. Additional 
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studies are required to understand the earliest mechanisms of CXCL13 production in FDCs, 
stromal cells, and DCs, but these studies are clear in the importance of CXCL13 for immune 
control of Mtb and protective ectopic lymphoid follicle formation in the lung. These studies have 
contributed greatly to the understanding of Mtb immune responses and the formation of ectopic 
lymphoid organs during infection. 
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5.0  CONCLUSIONS, SIGNIFICANCE AND FUTURE DIRECTIONS 
M. tuberculosis is the causative agent of the disease that causes tuberculosis, which has multiple 
outcomes including active, latent and reactivated disease 
229, 278
. Latent TB patients are 
asymptomatic and 90% can live a lifetime harboring the bacteria without ever developing 
reactivated infection and complications 
278
. Further, these patients are at little risk to other 
individuals as bacteria is only transmitted during active infection 
278
. Thus, the immune 
components required for maintaining latent infection are important in understanding protective 
immunity and immune control. It was previously understood that CD4
+
 Th1 cells are necessary 
to activate macrophages through IFNand TNF production, which stimulates macrophages to 
upregulate iNOS and contribute to bacterial killing 
51
. Further, the granuloma, the hallmark of 
Mtb infection, is thought to facilitate cross-talk and provide a physical barrier for the prevention 
of bacterial spread and to limit pathology. However, the granuloma forms in both active and 
latent disease indicating immune differences exist in generating a functional and protective 
granuloma. The lack of latent Mtb infection models limits the work in this area.  However, using 
a combination of human, NHP, which develop latent disease, and the Mtb mouse model, which 
is invaluable for mechanistic studies, evidence has emerged on granuloma formation in latent, 
active, and chronic disease. 
Previous work has established the presence of B cell lymphoid aggregates within the 
granuloma of humans 
11
, NHPs 
78
, and mice 
24, 77
. Development of lymphoid follicles was 
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associated with development of L-TB in some humans 
223
. Our data proves that these lymphoid 
follicles are ectopic lymphoid organs that indeed correlate with immune control as 100% of L-
TB NHPs formed ectopic follicles while only 33% of samples from NHPs with A-TB contained 
proliferating GC B cells, FDCs, and CXCR5
+
 T cells. Importantly, we mechanistically addressed 
the formation of ectopic lymphoid follicles and the cells required for protective immunity. We 
found that expression of CXCL13 by stromal cells, FDCs, and DCs were critical for ectopic 
lymphoid follicle formation and recruitment of CXCR5
+
 T cells within the lung. CXCL13 was 
not required for CXCR5
+
 T cells to migrate to the lung, but was required for specific localization 
within the lung parenchyma. CXCR5
+
 T cells, which express dual characteristics of Tfh and Th1 
cells, are essential for controlling Mtb infection in mice by their production of Th1 
proinflammatory cytokines that promote macrophage activation and further contribute to ectopic 
lymphoid follicle development. This protective model is summarized in Figure 25. 
Our study highlights the importance of CXCL13 induction, CXCR5
+
 T cell recruitment 
and formation of ectopic lymphoid follicles in the generation of a protective Mtb immune 
response. Further, these data support the hypothesis that T helper cells exhibit degrees of 
plasticity and can express multiple lineage characteristics. In addition, they support the idea that 
effective granuloma formation does contribute to protective immunity and that significant 
differences exist in both morphological and physiological parameters indicating future diagnostic 
tools may easily be able to differentiate between active and latent TB disease. 
 Although it is difficult to mechanistically determine the role of the CXCL13/CXCR5 
axis in human TB, much work can be performed to validate this hypothesis. Our data translated 
into humans could have extensive implications in diagnostics of L-TB and A-TB and can  
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potentially indicate those individuals reverting to active disease. CXCL13 levels or CXCR5 
expression in the serum or BAL could differentiate those with L-TB, A-TB, or those at risk for 
reactivation. In humans, individuals with specific genetic mutations are predisposed to increased 
mycobacterial infections such as those in the IFN locus (discussed in section 1.3.2). It is 
possible that specific populations with single-nucleotide polymorphisms in the Cxcr5 or Cxcl13  
 
 
Figure 22: CXCR5 expressing T cells mediate protective immunity against tuberculosis.  
Dendritic cells become activated following uptake and processing of Mtb antigen in the lung. Following activation, 
DCs upregulate CCR7 and migrate to the draining lymph node in response to CCL19/CCL21 chemokines. DCs 
present antigen to naïve T helper cells, which differentiate into Tfh-like Th1 cells, which express CXCR5. CXCR5+ 
Th1 cells migrate to the lung in response to inflammatory chemokines. Upon arrival to the lung, CXCR5+ Th1 cells 
use CXCL13 to specifically localize to Mtb-infected phagocytes within the parenchyma. Localization of CXCR5+ T 
cells typically results in the formation of ectopic lymphoid follicles containing CXCR5+ T cells, GC B cells, FDCs, 
and other myeloid cells, which are strongly associated with latent TB. Localized CXCR5+ Th1 cells produce 
IFNand TNF, which act to activate macrophages and kill Mtb thereby assisting in the host protective immune 
response. 
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locus may have a higher incidence rate of Mtb infections and have a higher risk for reactivation. 
Further, our study also provides the rationale for targeting CXCR5 expression on memory T cells 
in vaccine immunity. Accordingly, studies have reported that the use of IL-6 as a vaccine 
adjuvant drives CXCR5 expression on T cells suggesting this is a distinct possibility 
279
. 
Therefore our mechanistic studies using the mouse model of Mtb may have a broader relevance 
in human TB disease. Our findings may also have direct implications in other diseases both 
autoimmune and infectious. These results with other studies implicate ectopic lymphoid follicles 
as both mediators of protection and autoimmune pathology suggesting location and 
circumstances determine the role of this structure.  
The future directions of this investigation will involve study of the mechanisms driving 
induction of CXCL13 and ectopic lymphoid follicle formation. Previous studies 
35
 have found 
pulmonary expression of TNF- and LT- in Mtb-infected mice, both known to induce 
CXCL13 expression, but it is not known if one, both, or neither of these cytokines is responsible. 
Further, it is also possible that Mtb may directly induce CXCL13 expression through TLR 
stimulation 
280
. IL-17, which is implicated in the formation of ELOs in influenza 
176
, is also 
induced during Mtb infection 
80
. Further, Il-23-/- mice lacked organized ELOs later in infection 
suggesting IL-17 may play a role in maintenance of ELO formation during chronic TB 
281
. 
Moreover, the impact of Cxcl13 and Cxcr5 deficiency, on vascular adhesion molecule 
expression, chemokine production, and chemokine receptor expression should be investigated as 
these may also contribute to correct localization of T cells within the granuloma. To gain further 
insight, it would also be beneficial to take advantage of gene expression microarrays to define 
specific activation profiles of CXCR5
+
 and CXCR5- CD4
+
 T cells.  
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Additional studies investigated the protective role of CXCR5/CXCL13 and ELO 
formation in vaccine induced immunity is essential. Indeed, further work done in our lab 
indicates ELOs are induced in mice mucosally vaccinated with ESAT61-20 peptide and formation 
is dependent upon CXCL13 expression 
282
. Further, Cxcl13-/- mice were unable to generate a 
protective vaccine induced immune response following challenge with Mtb 
282
. Induction of 
CXCL13 was dependent upon IL-17, but not IFN production suggesting IL-17 is also involved 
in protective vaccine induced ELO formation 
282
. It is clear that expression of CXCL13 is 
essential in the Mtb mouse model for protective vaccine induced immunity. 
Our data further support the idea that T helper cells are plastic, capable of expressing dual 
characteristics of both Tfh and Th1 lineage cells. Tfh cells appear to be the most dynamic subset 
as in vitro Tfh cells can become Th1, Th2, and Th17 cells 
283
. Further, Th1 cells pass through a 
Tfh-like transition before they become fully committed Th1 cells 
258
. It is possible that this Tfh-
like Th1 transition state is critical in Mtb immunity. CXCR5
+
CD4
+
 T cells in Mtb infection 
could utilize CXCR5 expression to migrate into the parenchyma and position in the granuloma, 
but then down regulate CXCR5 and become fully committed Th1 cells. The exact benefit of T 
cell plasticity in Mtb infection and the cytokines that drive this transition require further study. 
In summary, our data describe a novel and previously undescribed role for CD4
+
CXCR5
+
 
Th cells in Mtb protective immunity through localized proinflammatory cytokine production and 
macrophage activation. As we further elucidate the immune mechanisms required for protective 
immunity against TB, targeted efforts can be made to improve vaccine strategies, diagnostics, 
and treatment against this pulmonary pathogen. 
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